Visit our Location
11860 Vista Del Sol Dr Suite 105,
El Paso, TX 79936
Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Category: Estrogen Balance

ChiroMedBlogBioidentical Hormone Replacement Therapy in El Paso, TXEstrogen Balance

Estrogen plays a key role in energy, mood, metabolism, bone health, skin health, and reproductive wellness. When estrogen levels are too high, too low, or out of balance with other hormones, it can lead to symptoms such as hot flashes, night sweats, weight changes, brain fog, mood swings, and sleep problems. We evaluate how estrogen affects the body, common signs of imbalance, testing options, and integrative strategies that may help support healthier hormone balance.

Pellet Therapy: What You Need to Know About Subcutaneous Hormones

Get insights into subcutaneous hormones in pellet therapy and its role in enhancing hormonal balance and well-being.

Abstract

In this educational post, I walk you through a clear, step-by-step approach to modern subcutaneous hormone pellet placement and peri-procedural care, drawing from current evidence, practical demonstration using ballistic gel, and my clinical observations in integrated practice. You will learn:
How to prepare the field and orient anatomy for safe, consistent pellet delivery
Why do bevel orientation, trocar locking, and the two-hand technique prevent tissue trauma and pellet migration
How to use the anesthetic weal and track anesthesia to minimize pain and avoid superficial placement
Precise depth, angle, and spacing strategies that reduce encapsulation and extrusion
Post-procedure closure and dressing that supports optimal healing
How integrative chiropractic care complements pellet therapy by optimizing biomechanics, lymphatic flow, autonomic tone, and recovery
Throughout, I translate the latest findings into practical steps, with physiological explanations, so you can understand not just what to do but why each move matters. I also include real-world tips on supplies, alternatives for shortages, and ergonomic technique refinements that improve outcomes for both male and female patients.

Getting Started: Intentional, Patient-Centered Technique

I’m Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. As both a chiropractor and nurse practitioner working in an integrative model, my goal is to deliver precise, low-trauma procedures guided by evidence and informed by years of hands-on care. When training practitioners, I often see how good people can drift into habits that subtly increase tissue trauma or pellet-related complications. Today, I focus on building the right habits with a clear, repeatable method you can bring into practice immediately.
Core Principles:
Respect tissue planes and fascia to reduce nociception, inflammation, and fibrotic response.
Use instruments as depth and orientation landmarks.
Maintain consistent force vectors using a two-hand, elbow-locked technique.
Place pellets in stable, well-vascularized subcutaneous fat, not in superficial dermal/fascial layers.
Keep everything within the field of anesthesia to ensure patient comfort.
Close with tension-minimizing techniques to support re-approximation and reduce extrusion.

Why Ballistic Gel Teaches What the Eye Misses

For teaching, I use clear ballistic gel because it behaves like soft tissue while letting you see your mistakes and successes. In live tissue, you feel resistance changes; in gel, you can also see how the trocar tip, bevel, and obturator shift planes, how pellets line up or scatter, and where tissue displacement occurs.
Physiologic takeaway: Human subcutaneous tissue is viscoelastic. If you push with a single hand and an unlocked elbow, force translates into tip wobble, creating micro-tears and uneven tracks. A steady, locked-elbow two-hand technique preserves a clean corridor, reducing inflammatory signaling and later scar formation.

Key Instrument Concepts: Trocar, Obturator, Bevel, and Lock

The obturator is the inner stylet. We remove it to load pellets, then reinsert the delivery pusher as needed—never removing the entire trocar from the track unless we are finished with that pass.
The bevel should be buried and oriented to glide through subcutaneous fat, not to cut into fascia. Twisting a sharp-beveled trocar while advancing can rupture tissue planes—this is a common cause of post-procedure discomfort and fibrosis.
Always ensure the trocar is in its locked position before advancing. Using an unlocked tip forces the blunt end through tissue, increasing trauma and bleeding.

Anatomy Mapping: Landmarks, Planes, and Patient Comfort

For male gluteal placement:
Identify the iliac crest and the lower “lip” of the crest.
Palpate the erector spinae border laterally to appreciate the transition to gluteal fat.
Aim laterally enough to avoid midline structures, but not so far laterally that you drift toward areas with higher shear forces or where the patient might sit directly on the pellets.
For female gluteal/upper buttock placement:
Choose an upper buttock area inside the “tan line” zone where subcutaneous fat is sufficient, and sitting pressure is minimal.
Avoid overly lateral placement to prevent irritation from tight garments and excessive motion.
Place where the patient will not sit on the pellets—this reduces shear, pain, and the risk of extrusion.

Physiology of Good Placement

The subcutaneous fat layer provides a compliant, perfused environment with lower mechanotransduction stress than the superficial dermis/fascia.
Pellets placed too superficially (in the fascial plane) trigger fibroblast activation, collagen deposition, and encapsulation. Patients may palpate tender nodules; absorption can become inconsistent.
Deep, evenly spaced pellets within subcutaneous fat distribute local pressure, reduce frictional shear, and maintain more predictable pharmacokinetics.

Creating a Pain-Free Track: The Anesthetic Weal


I stress the value of a generous, well-placed anesthetic weal:
Create a visible, raised weal in the skin and superficial subcutis at the entry point.
Advance with a small-gauge long needle, infiltrating along the planned track.
Why it works: Local anesthetic blunts nociceptive input, allowing slower, deliberate advancement. It also creates a hydrodissection effect—gently separating tissue planes and reducing the risk of micro-tears as the trocar follows.

Technique Optimization: Angle, Depth, and the Two-Hand Method


Target angle: Approximately 45 degrees relative to the skin surface, adjusted to maintain subcutaneous trajectory without diving into muscle.
Target depth: About 1.0 to 1.5 inches below the skin surface for most patients, guided by palpation and patient habitus; use the anesthetic needle length as a landmark, as many modern delivery systems match trocar length to needle length.
Two-hand method: Lock your elbow against your torso. The non-dominant hand stabilizes and opposes the tissue; the dominant hand advances the trocar. This minimizes longitudinal wobble and prevents pellets from migrating toward the incision.

Spacing Pellets: Laying Them Down in a Track

Load pellets while the trocar is stabilized—do not “syringe-push” with one hand, which creates pellet stacking, tenting, or backflow toward the incision.
After each pellet, slightly retract to the locked position, reorient the tip laterally within the same subcutaneous plane, then advance gently to lay the next pellet just distal to the last.
Aim for even spacing along the track rather than a cluster. Even spacing reduces localized pressure and fosters consistent absorption.

What Happens If You Go Too Superficial?

Superficial placement within the dermal/fascial layers increases the risk of encapsulation: fibroblasts deposit collagen around the pellet in response to mechanical irritation and cytokine signaling (TGF-β, IL-1β). Patients may feel sharp, mobile nodules; sometimes they are visible.
Clinically, superficial pellets can extrude through the incision, especially if closure tension is poor or the patient loads the area early (e.g., sitting, exercise).
In my practice, when a patient reports palpable, sharp pellets near the incision after a prior procedure, it is almost always a depth and plane issue. This is correctable with better mapping, adequate weal/track anesthesia, and disciplined two-hand delivery.

Male vs Female Considerations

Male patients often have thicker fascia and variable fat distribution. Use a slightly deeper approach, but stay within the subcutaneous fat. Avoid the fascial layer beneath the dermis; that’s where nodularity and pain start.
Female patients often have adequate upper-buttock subcutaneous tissue; place pellets in an area where sitting pressure is minimal. Ensure the angle and depth maintain a subcutaneous trajectory to avoid penetration of the gluteal muscle.

Instrument Handling: The “Lock” and the “Cup”

Always verify the trocar is locked before advancing. If the tip is out of the lock, the blunt end abrades tissue.
Use your non-dominant hand to “cup” under the loading hand during pellet insertion. This stabilizes the device and prevents micro-movements that displace pellets.
Replace the obturator or pusher carefully and avoid withdrawing completely from the track until you are done with that run of pellets.

Closure That Protects Your Work

After pellet delivery, apply gentle pressure to express any excess fluid without milking pellets toward the incision.
Approximate the edges using a skin adhesive with a small, tension-minimizing pattern, then apply a pressure dressing.
I often use a two-stage closure:
An inner approximation with a skin adhesive strip or sterile adhesive mesh that holds the dermal edges together.
A short-term pressure bandage arranged in a “T” configuration over the incision to counter early shear and reduce hematoma.
Post-care instruction matters: Keep the area dry; for 3 days, avoid immersion (e.g., tub baths) and strenuous gluteal loading. Breathable adhesive can be left until it releases naturally.

Why Triamcinolone-Containing Pellets May Reduce Tissue Reaction

Some modern pellets contain a microdose of corticosteroid (e.g., triamcinolone) designed to reduce local inflammation and modulate fibroblast collagen deposition around the implant.
Mechanism: Corticosteroids downregulate pro-fibrotic pathways (e.g., TGF-β/SMAD) and diminish local cytokine-driven edema.
Clinical payoff: Lower rates of palpable fibrosis and encapsulation; smoother recovery.

A Word on Supplies, Shortages, and Safe Substitutes

Occasionally, clinics encounter shortages of chlorhexidine or specific kits. Practical options:
Skin prep: Chlorhexidine-alcohol remains superior for microbial kill rates, but povidone-iodine or 70% isopropyl alcohol are acceptable alternatives when used correctly (allow full contact time).
Needles and kits: Verify sterility and length parity with your trocar system. If ordering from third-party vendors, check lot numbers and packaging integrity.


Avoiding Common Errors

One-handed “syringe” push: Tends to jet pellets forward or backward, creating stacking or back-migration toward the incision.
Over-rotation of the trocar: Can lacerate fascia and create a painful track.
Shallow track creation: Leads to visible pellets, patient tenderness, and an increased risk of extrusion.
Over-advancement beyond an anesthetized field: Increases pain and sudden patient movement.

Troubleshooting In Real Time

If pellets are drifting toward the incision, you are pushing without stabilizing. Re-establish the two-hand lock, retract to the lock position, and re-advance gently.
If tissue tents: You are too superficial or pushing too hard; pause, deepen slightly to subcutaneous fat, and slow the advance.
If the patient reports a sharp “zing,” You may have approached fascia or nerve-rich areas; reorient more laterally within the subcutaneous tissue and proceed after re-anesthetizing the track if needed.

Integrative Chiropractic Care: Enhancing Outcomes Around Pellet Placement

As a chiropractor and functional medicine clinician, I integrate musculoskeletal care before and after pellet placement to improve circulation, lymphatic drainage, and autonomic balance.
Why chiropractic integration helps:
Biomechanics: Balanced pelvic and lumbosacral mechanics reduce shear on the pelvic site and mitigate asymmetric tension on the gluteal fascia.
Lymphatic flow: Gentle soft-tissue and lymphatic techniques promote efficient interstitial fluid movement, reducing edema around the insertion site.
Autonomic tone: Parasympathetic-enhancing strategies (breathing drills, rib/thoracic mobility work) reduce sympathetic drive and pain perception, supporting smoother recovery.
Clinical observations from practice:
Patients receiving targeted lumbopelvic adjustments and myofascial work pre-procedure consistently report lower post-procedure soreness and demonstrate fewer superficial adhesions at follow-up.
Coordinating insertion on the less-loaded side (based on gait analysis) tends to reduce early shear forces.
Light, graded gluteal mobility work begins after the initial 72-hour window to encourage pliability in subcutaneous planes without disrupting the track.
For more on our integrated approach and case-driven outcomes, see my clinical updates and practice insights on my website and professional profile:
ChiroMed: https://chiromed.com/
Professional insights: https://www.linkedin.com/in/dralexjimenez/

Evidence-Based Rationale: Pain, Inflammation, and Tissue Mechanics

Nociception and procedural pain: Minimizing needle/trocar torque and staying within anesthetized fields dampens C-fiber activation. The anesthetic weal and hydrodissection reduce mechanical coupling to nociceptors.
Edema control: Clean tracks and precise closure limit exudate accumulation. Pressure dressings reduce dead space and shear, lowering the risk of seroma and extrusion.
Fibrosis prevention: Avoiding fascial disruption and using microdose steroid pellets (when the product design includes them) reduces fibroblast activation. Even pellet spacing prevents localized pressure necrosis and inflammatory signaling.

Step-by-Step Summary You Can Use Tomorrow

Map landmarks: Iliac crest, erector spinae margin, upper buttock safe zone.
Prep and drape: Use chlorhexidine-alcohol when available; alternatives include povidone-iodine or alcohol.
Create a robust anesthetic weal at the entry; infiltrate along the entire intended subcutaneous track.
Incision: A small, controlled incision aligned with the planned track to reduce shear across the wound.
Trocar entry: Tip locked, bevel buried, 45-degree approach to maintain subcutaneous depth.
Two-hand technique: Elbow locked to torso; non-dominant hand opposes and cups; dominant hand advances.
Pellet loading: Keep within the anesthetized field; retract to lock between pellets; space evenly along the track.
Final check: Ensure no superficial tenting; gently compress to clear fluid without expressing pellets.
Closure: Approximate edges with skin adhesive/strips; apply a pressure “T” bandage; give clear aftercare instructions.
Integrative follow-up: After 72 hours, resume gentle mobility and, if indicated, integrative chiropractic care to optimize biomechanics and lymphatic function.

Why This Method Works

Every element here reduces variables:
Angle and depth keep you in the right tissue plane.
The weal-and-track anesthesia reduces pain and defensive muscle guarding.
Two-hand stability protects the track and pellet spacing.
Proper closure reduces the risk of shear and extrusion.
This is modern, precision-guided tissue management—simple, reproducible, and kind to the body.

Patient Education Talking Points

You should not feel sharp pellets close to the skin. If you do, contact us.
Mild soreness is normal; avoid soaking the site and heavy gluteal loading for three days.
Keep the dressing clean and dry; let adhesive strips fall off naturally.
Report any increasing redness, warmth, or drainage.

From Training Room to Clinic Floor

In training, I often have clinicians work in a cadence: five pellets, then one, practicing the lock-retract-advance rhythm. Starting centrally and spreading laterally within the same plane produces consistent results. When in doubt, slow down, re-check the wheel, confirm the lock, and honor the tissue.

Closing Thoughts

Great outcomes follow great habits. With disciplined instrument handling, a respect for tissue planes, and an integrative approach to recovery, pellet procedures can be consistent, comfortable, and durable. Blend these steps with your clinical judgment, use your tools as landmarks, and keep your patient’s comfort at the center of every move.

References


SEO tags: hormone pellets, subcutaneous pellet placement, trocar technique, obturator, anesthetic weal, encapsulation prevention, pellet extrusion, gluteal anatomy, integrative chiropractic, lymphatic drainage, pressure dressing, chlorhexidine prep, triamcinolone microdose, tissue mechanics, fascia, subcutaneous fat, pain control, procedural ergonomics, Dr. Alexander Jimenez, DC, APRN FNP-BC, CFMP IFMCP ATN CCST

Functional Hormone, Thyroid, and Pellet Care Solutions

Functional Hormone, Thyroid, and Pellet Care Solutions

Functional Hormone, Thyroid, and Pellet Care Solutions

Abstract

In this educational post, I walk you through a clear, clinic-tested roadmap for optimizing hormones, metabolism, thyroid function, and pellet therapy using modern, evidence-based methods. I explain how to time lab testing for accurate interpretation, build patient-centered schedules that match physiology, and use symptom checklists to validate outcomes. I detail how to interpret complex panels for postmenopausal women and middle-aged men, why we focus on free hormones (like free testosterone), and how metabolic markers (such as SHBG, CRP, and A1C) influence dose-response. I share practical pellet-technique pearls—placement depth, diffusion surface area, and fascia-sparing methods—and explain why these mechanics matter physiologically. I also describe how integrative chiropractic care amplifies endocrine and metabolic gains by improving biomechanics, autonomic balance, sleep quality, and movement.

Why A Systems Approach Outperforms Single-Variable Care

When I optimize endocrine and metabolic health, I never treat a lab value in isolation. The endocrine, metabolic, and nervous systems constantly communicate with each other. If we address hormones without supporting biomechanics, sleep, autonomic tone, and tissue nutrition, gains stall.

  • The thyroid-pituitary feedback loop modulates energy production at a mitochondrial level; poor sleep and sympathetic overdrive downregulate receptor sensitivity even when labs look fine (Bianco & Kim, 2006).
  • Free testosterone—not just total—drives androgen receptor activation that supports muscle, motivation, and vascular health; low values often reflect insulin resistance and SHBG dynamics (Antonio et al., 2016; Tosi et al., 2019).
  • Adipokines and low-grade inflammation elevate CRP and alter lipoproteins; until we reduce inflammatory signaling, lipid panels rarely normalize durably (Khera et al., 2018).

My integrative model aligns treatment timing, movement prescriptions, sleep rehabilitation, and nutrient strategies with pharmacology so signals converge on the same physiologic target.

Patient-Centered Testing Timelines That Improve Accuracy and Outcomes

I design lab timing to reduce noise and improve decisions. Certain short windows capture acute effects; mid-range follow-ups catch homeostatic recalibration.

  • For immediate effects relevant to the therapy, I may collect data at 45 minutes post-dose and reassess at 1 week to assess stabilization trends.
  • For structured follow-ups that match tissue-level adaptation, I evaluate at 5–8 weeks, when hormone receptor expression, transport proteins, and downstream markers (CRP, fasting glucose, lipids) begin to shift.
  • I schedule program visits at around 14 weeks for females and 18 weeks for males to align with the average time required to consolidate symptom and laboratory improvements.

Why this works:

  • Short windows observe changes in transport and receptor occupancy while avoiding false reassurance from transient peaks.
  • The 5–8-week frame aligns with deiodinase regulation, hepatic lipoprotein remodeling, and receptor-level recalibration (Bianco & Kim, 2006).
  • Pre-scheduling prevents drift, missed troughs, and attribution errors that occur when feedback arrives months too late.

Streamlined Access, Clear Instructions, and Real-Time Support

Patients do best when expectations are unambiguous. In my offices, we combine telemedicine, transparent pricing, and simple onboarding with digital and print instructions.

  • We provide 4×6 QR-coded cards that link to short videos and a concise PDF, explaining post-visit steps and when to return.
  • Automated nudges at 3 weeks remind patients to schedule the next appointment or complete a recommended study.
  • This approach lifts anxiety, reduces call volume, and boosts adherence by delivering instructions exactly when they matter.

Scheduling To Physiology: Purposeful Follow-Ups With Bell-Curve Planning

I never say “call when you’re ready.” We schedule the next contact before the patient leaves to align with the physiologic window of responsiveness.

  • Typical cadence: ~14 weeks for women and ~18 weeks for men, with individual adjustments.
  • Outliers exist; if a woman feels exceptional at 8 weeks but “off” at 14, I shift to ~12-week intervals.
  • Older adults sometimes sustain benefits for 6–9 months with careful monitoring.

This bell-curve-informed planning captures the optimal range of neuroendocrine recalibration while respecting variability.

Validating Care With Symptom Checklists and Real-World Activity Detail

I use sex-specific symptom checklists at baseline and follow-up. Patients score fatigue, mood, sleep, libido, gastrointestinal comfort, pain, and function.

  • We expect scores to fall as therapy takes hold—evidence of clinical benefit that pairs with labs.
  • I always ask for precise activity data: type, frequency, duration, heart rate, and exertion.
  • Why it matters: androgen utilization, oxygen demand, and mitochondrial load differ dramatically between a powerlifter and a casual walker. Dosing and expectations must match the physiologic request placed on tissues.

Checklists are my compass; activity specifics are my map.

Postmenopausal Women: Thyroid Autoimmunity, Nutrient Repletion, and Gut-Thyroid Axis

A frequent presentation in my clinic is a postmenopausal woman with fatigue, weight gain, digestive discomfort, mood changes, and low libido. Common lab patterns include:

  • Elevated TSH (e.g., 20+) with low free T3/T4, plus TPO antibodies consistent with autoimmune thyroiditis (Hashimoto’s) (American Thyroid Association, 2014/2019).
  • Ferritin is below the target ranges for robust thyroid hormone synthesis.
  • B12 below the performance zone (I prefer B12 > 800 pg/mL for neurocognitive resilience).
  • Vitamin D3 adequate but functionally low for bone and immune modulation if dosing has been modest and prolonged.

Physiology and clinical reasoning:

  • High TSH reflects pituitary drive; low free hormones indicate inadequate production or conversion. I typically initiate levothyroxine (T4) and consider combination T3/T4 when peripheral conversion remains poor despite optimizing gut and hepatic conditions.
  • I replete ferritin, B12, and vitamin D3/K2 to remove bottlenecks in synthesis and receptor function. Vitamin K2 pairs with D3 to support calcium handling and reduce ectopic deposition, protecting vascular health (Schwalfenberg & Genuis, 2017).
  • I address dysbiosis and motility. The gut-liver-thyroid axis modulates deiodinase activity; LPS and cytokine load suppress T4-to-T3 conversion (Virili & Centanni, 2015).

Integrative chiropractic care fit:

  • By normalizing spine and pelvic mechanics, decreasing nociception, and reducing sympathetic overactivity, we improve vagal tone, sleep, and bowel regularity—conditions that enhance thyroid receptor signaling. In my practice, pairing manipulative therapy with breathing retraining and gentle neuromuscular reeducation consistently amplifies endocrine responses. Explore my clinical observations: ChiroMed El Paso and professional updates on LinkedIn.

Middle-Aged Men: Free Testosterone, SHBG, Adipokines, and Cardiometabolic Risk

In men around their late 50s, I often see changes in gait, low motivation, muted enthusiasm, and physical exhaustion. Labs may reveal borderline total testosterone (~300 ng/dL) but low free testosterone (e.g., ~7)—clinically hypogonadal (Endocrine Society, 2018).

Key insights:

  • Free testosterone activates androgen receptors in muscle, brain, and endothelium, supporting protein synthesis, motivation, and lipid oxidation (Antonio et al., 2016).
  • Low SHBG flags insulin resistance and visceral adiposity, not merely a binding issue (Tosi et al., 2019).
  • Elevated CRP and A1C predict cardiometabolic risk and interfere with optimal androgen signaling (Khera et al., 2018).

Clinical approach:

  • Focus on restoring free T, not just total. If indicated after risk assessment, consider TRT with careful monitoring for hematocrit, prostate health, and cardiometabolic status (Endocrine Society, 2018).
  • Treat the metabolic core: structured resistance training, interval conditioning, sleep optimization, and targeted nutrition. As insulin sensitivity returns, endogenous androgen tone often improves.

Integrative chiropractic care fit:

  • I address lumbopelvic stability, thoracic mobility, and cervical alignment to correct proprioceptive inputs and reduce pain-mediated sympathetic tone. Improved sleep (deeper slow-wave stages) supports growth hormone pulses and insulin sensitivity (Vgontzas et al., 2009). When combined with breathing mechanics and balance drills, men report reduced perceived effort during exercise and improved adherence.

Comprehensive Panels: Why We Measure Beyond Cholesterol

A standard lipid profile misses most of the story. My core panels include:

  • A1C for glycemic memory, hs-CRP for inflammation, and lipid subfractions (small dense LDL).
  • Liver enzymes, mindful that modern reference ranges have shifted with population-level obesity.
  • B12, ferritin, vitamin D3/K2, and a thyroid panel with antibodies when indicated.

Rationale:

  • Inflammation and thyroid status alter lipoprotein behavior and LDL receptor expression. Lipid improvements often lag until CRP and visceral fat fall—usually after months of multi-system optimization (Khera et al., 2018; American Thyroid Association, 2014/2019).

Dosing To Activity and Physiology: Why Similar Labs Require Different Plans

Two patients with similar lab numbers do not necessarily need the same dose. The androgen receptor landscape, oxygen demand, and mitochondrial throughput vary with age, training status, sleep, and stress.

  • Highly active individuals often require slightly more robust dosing or faster titration due to higher tissue uptake and turnover.
  • Less active patients may respond to lower doses if we emphasize sleep depth, stress reduction, and progressive strength training.

I use structured algorithms that consider age, goals, comorbidities, and activity patterns. Then I adjust based on the 5–8-week and 14–18-week reassessments.

Safety, Compliance, and Controlled-Substance Stewardship

Because testosterone is a controlled substance, I run strict inventory and documentation:

  • Every tablet and lot number is logged; every administration links to a patient, dose, and lot.
  • Daily reconciliation maintains zero-gap accountability.
  • This rigor protects patients, supports regulatory compliance, and reinforces trust.

Digital Decision Support: Accuracy At Scale Without Replacing Judgment

I rely on dosing and resource centers that integrate:

  • Order sets, color-coded protocols, and inventory control.
  • Algorithms that adjust for cancer history, age, sex, and activity.

Nuance: context selection matters. For example, checking a generic “breast cancer” box for a 10-year disease-free survivor with bilateral mastectomy can overly restrict the tool’s suggestions. Accurate context plus clinical judgment prevents under-treatment while maintaining safety.

Integrative Chiropractic Care: The Physiologic Multiplier

Hormones do not operate in a vacuum. Spinal alignment, joint mobility, and breathing mechanics influence autonomic tone, oxygenation, and neuroimmune signaling.

  • Reduced nociception lowers sympathetic drive, improving parasympathetic (vagal) tone, digestive motility, and insulin sensitivity.
  • Improved ribcage and diaphragmatic mechanics enhance oxygen delivery and CO₂ regulation, supporting mitochondrial performance—vital for fatigue and brain fog.
  • Neuromuscular reeducation boosts proprioception and balance, encourages consistent strength training, and, downstream, normalizes adipokine and CRP levels.

In my El Paso practice, the combination of hands-on care with endocrine optimization consistently outperforms either strategy alone. See case reflections and clinical notes at ChiroMed and on my LinkedIn profile.

Practical Pellet Therapy: Tissue Planes, Surface Area, and Sterile Precision

Pellet therapy provides steady-state hormone exposure when executed precisely. The technique matters:

  • Optimal plane: deep subcutaneous adipofascial layer over gluteal or flank regions provides perfusion and mechanical stability for consistent elution.
  • Depth, not superficial: shallow placement increases palpability, extrusion, microhematomas, and erratic kinetics.
  • Surface area strategy: lining pellets in a single rail or on parallel rails increases the effective diffusion surface area, yielding smoother pharmacokinetics.

Physiology:

  • Proper depth places pellets in tissue with stable microcirculation and intact fibrous septae, which gently “anchor” the implant and resist mechanical irritation.
  • Lined spacing increases the interface for diffusion, reducing early spikes and late troughs. Materials like ethyl cellulose further smooth the rise and fall of serum curves (Chung et al., 2019; Glaser et al., 2013; Gittens & Leipzig, 2020).

Sterile Field, Hemostasis, and Closure: Reducing Pain and Scar While Protecting Kinetics

My clean-to-sterile workflow is disciplined:

  • Extend the sterile field, position the tray for minimal reach, and avoid talking over the site to reduce droplet contamination (Mangram et al., 1999).
  • Use a precise skin nick matched to the introducer to minimize cutaneous trauma.
  • Advance a tissue-sparing, conical-tip introducer along the deep subcutaneous plane, respecting fascial lines to reduce microvascular shearing and bruising.
  • Load pellets and use gentle thumb pressure with chamber retraction (not plunging) to set each pellet, preserving track integrity and placement accuracy.

For closure:

  • I apply anti-inflammatory agents laterally (not on the incision line), approximate with steri-strips, place a sterile 4×4 gauze, and finish with T-shaped compression tape to reduce dead space and bruising.
  • Clear aftercare: keep steri-strips in place for at least 5 days, avoid hot tubs and heavy sweating, and reduce lateral trunk strain to protect the early fibrin scaffold and the stability of the pellet pocket.

This approach reduces pain, bruising, and scar width, and lowers the risk of infection, while supporting predictable diffusion kinetics.

Follow-Up Cadence For Pellets: What To Measure and When

I align pellet follow-up with kinetics and patient function:

  • First check at 4–5 weeks: symptom score, blood pressure, side effects, and targeted labs when symptoms suggest overshoot or undershoot.
  • Quick touchpoint about a week later to confirm adjustments.
  • Program visit at ~14 weeks for women and ~18 weeks for men to consolidate changes, review labs as indicated, and plan next steps.

I avoid excessive early labs; clinical observation guides me. I test when the result would change management and at cadence points that reflect steady-state behavior.

The Postpartum Boost: A Single, Conservative Adjustment With Clear Guardrails

In postpartum care, I sometimes consider a single, conservative boost after reviewing baseline labs and symptom inventory. The goal is to stabilize function-limiting symptoms during a phase of hormonal turbulence.

  • Why only one boost: postpartum physiology is fluid; repeated escalations risk mood lability, mastalgia, acne, fluid shifts, and lactation changes. A single, minimal-effective dose clarifies the signal and protects the body’s recalibration trajectory.
  • I always check thyroid status and nutrient deficits (iron, vitamin D, omega-3), which frequently drive fatigue and pain.

After stabilization, I discontinue the boost and transition to supportive care. If symptoms persist, I reassess root causes rather than stacking therapies.

Evidence-Based Dosing Algorithms: Conservative Starts, Purposeful Adjustments

I rely on structured algorithms shaped by thousands of encounters:

  • Start low, go slow, to minimize androgenic or estrogenic side effects while capturing the majority of symptom relief.
  • Adjust with purpose after two to three half-lives, not prematurely.
  • In men with low free T but “normal” total T, I evaluate SHBG drivers and insulin resistance before escalating the total dose (Endocrine Society, 2018; Tosi et al., 2019).
  • In women with prolonged hypoestrogenism, I start conservatively and titrate gradually to avoid headaches, edema, and BP shifts as the endothelium reacquaints with estradiol signaling (The North American Menopause Society, 2023).

Adjunctive conservative DHEA support can help selected patients when laboratory findings and symptoms align, with vigilance for acne or mood changes.

Consent, Documentation, and Risk Communication: Protecting Patients and Clinicians

My consent process reads like an accessible white paper:

  • I clarify FDA realities: while pellet procedures themselves are not FDA-approved, active ingredients and manufacturing are tightly regulated. I explain off-label use when applicable, backed by scientific rationale.
  • I list side effects by category (e.g., acne, mastalgia, mood shifts, erythrocytosis in men) and establish monitoring protocols (Sharma et al., 2015; Zaenglein et al., 2016).
  • I note where “normal ranges” differ in therapeutic contexts and stress trend-based interpretation to avoid snapshot errors.

Thorough consent, with references and signatures, creates transparency, improves adherence, and withstands scrutiny.

Managing Adverse Events and Setting Expectations

Patients deserve a plan for bumps in the road:

  • Early overstimulation: I prefer materials and spacing that smooth early peaks; hydration, magnesium, and guided breathing help dampen sympathetic surges. If needed, I adjust the dose or interval at the 4–5-week visit.
  • Acne flares: I use evidence-based skincare and, when indicated, adjust dose to limit DHT-driven sebaceous activation (Zaenglein et al., 2016).
  • Erythrocytosis in men: I monitor CBC, reduce dose, increase donation intervals, or change modality if hematocrit rises (Sharma et al., 2015).

Expectation setting reduces anxiety and improves partnership in care.

Nutritional and Lifestyle Foundations: Treat Supplements Like Prescriptions

I list supplements and lifestyle steps with the same clarity I would for prescriptions:

  • Vitamin D3 with K2: often 5,000–10,000 IU D3 for deficiency, paired with K2 to support bone and vascular health (Pilz et al., 2019; Schwalfenberg & Genuis, 2017).
  • Magnesium glycinate: supports sleep, muscle relaxation, and mood stabilization.
  • Omega-3 (EPA/DHA): reduces inflammation, improves mood, and supports lipids.
  • DIM/Calcium D-Glucarate, when estrogen metabolism support is indicated to favor beneficial pathways (Lindsay et al., 2021).
  • Protein intake of 1.2–1.6 g/kg during the healing phase supports collagen synthesis and angiogenesis.

Clear dosing schedules, rationale, and a take-home bag improve adherence and outcomes.

Case Synthesis: Turning Data Into Decisions

For a 59-year-old woman with TSH elevation, low free T3/T4, and high TPO antibodies:

  • Start levothyroxine; consider a T3/T4 combination if conversion remains poor after optimizing gut health and nutrition (American Thyroid Association, 2014/2019).
  • Replete ferritin, B12, vitamin D3/K2; treat dysbiosis.
  • Integrate chiropractic care: spinal-pelvic alignment, breathing mechanics, and neuromuscular reeducation to normalize autonomic tone.
  • Reassess at 5–8 weeks, program visit at ~14 weeks.

For a 59-year-old man with low free T, low SHBG, and elevated CRP/A1C:

  • Address insulin resistance with training, sleep, and nutrition; consider TRT after risk assessment (Endocrine Society, 2018).
  • Monitor hematocrit, lipid subfractions, CRP, and liver enzymes.
  • Integrate chiropractic care for lumbopelvic stability and thoracic mobility; add breathing mechanics and balance drills.
  • Reassess at 5–8 weeks, program visit at ~18 weeks.

Why Lipids Improve After Hormone and Lifestyle Optimization

Patients often ask why lipids normalize after a year. The cascade is predictable:

  • Inflammation declines: lower CRP improves hepatic lipoprotein handling (Khera et al., 2018).
  • Visceral fat decreases: adiponectin rises, harmful adipokines drop, and insulin sensitivity improves.
  • Thyroid optimization increases LDL receptor density, accelerating clearance (American Thyroid Association, 2014/2019).
  • Better sleep and regular exercise increase AMPK activity, enhancing fat oxidation.

The system becomes more resilient, and the lipid panel follows.

Bringing It All Together: Precision Meets Whole-Person Care

My overarching strategy:

  • Measure comprehensively and time labs intelligently.
  • Pre-schedule to match physiology (14 weeks for women, 18 weeks for men on average).
  • Use symptom checklists and activity details to guide titration and validate care.
  • Address thyroid, metabolism, and gonadal axes in sequence with conservative, evidence-based dosing.
  • Execute pellet therapy with tissue-respecting technique—correct depth, proper spacing, and meticulous sterile procedures.
  • Integrate chiropractic care to harmonize autonomic tone, biomechanics, sleep, and movement, amplifying biochemical interventions.
  • Support patients with QR videos, PDFs, and outbound nudges to reduce anxiety and calls.
  • Maintain rigorous controlled-substance stewardship.

I have seen this model raise patient satisfaction, improve objective markers, and create a trustworthy, reproducible clinical flow.

References

Integrative Hormone Health and Metabolic Resilience

Integrative Hormone Health and Metabolic Resilience

Integrative Hormone Health and Metabolic Resilience

Abstract

This educational post presents a practical, evidence-based roadmap for addressing complex hormone health, pelvic bleeding, urinary and infectious issues, metabolic and thyroid considerations, perimenopause, sleep, cognition, and gut-brain integration. As Dr. Alexander Jimenez, I present evidence-based strategies integrating precision diagnostics, lifestyle medicine, nutraceuticals, and chiropractic care, informed by my clinical experience and peer-reviewed research. I share structured decision trees for discontinuing high-risk oral contraceptives, evaluating postmenopausal bleeding, optimizing testosterone therapy, avoiding unnecessary antibiotic treatments, supporting reproductive planning with genetic counseling, and stabilizing mood and cognition through gut, sleep, and nervous system interventions. This post provides clear protocols, rationales, and physiology so you can understand not only what to do but also why it works.

Introduction: How I Approach Complex Cases With Modern, Evidence-Based Care

As a clinician working at the intersection of chiropractic medicine, family practice, functional medicine, and integrative care, I see patients whose stories rarely fit into clear categories. The questions range from “Why am I bleeding months after menopause?” to “Is my testosterone causing water retention?” to “Do we treat group A strep in urinary infections?” to “How do we support a young adult with ADHD without overmedicating?” The answers require a blend of physiology, clinical judgment, careful monitoring, and a collaborative strategy that respects both modern guidelines and whole-person health.

Over the years, I have refined protocols based on the current literature and what truly helps patients improve function and quality of life. Below, I walk you through a set of conceptual areas, each one grounded in research and enhanced by integrative chiropractic care to optimize neuromusculoskeletal balance, autonomic regulation, and rehabilitation outcomes. My goal is to help patients and clinicians understand the “why” behind every step.

Hormone Therapy Foundations: Physiology, Protocols, and Safety

Key themes

  • Hormones are signals that modulate cellular function across systems, including the nervous, immune, cardiovascular, bone, and metabolic networks.
  • The body seeks homeostasis; our job is to support signaling patterns, receptor sensitivity, and tissue-level responses without overdriving any pathway.
  • Precision dosing and monitoring reduce adverse effects and improve outcomes.

Physiological underpinnings

  • Estrogen supports endothelial function, neural plasticity, bone mineralization, and collagen integrity. In perimenopause, oscillations in estradiol can cause unpredictable vasomotor symptoms, mood shifts, and bleeding pattern variability as ovaries intermittently “kick back in.”
  • Progesterone modulates GABAergic tone in the brain, stabilizes the endometrium, and balances estrogenic proliferation in uterine tissue. It supports sleep and reduces anxiety for many individuals through neurosteroid pathways.
  • Testosterone influences erythropoiesis, muscle protein synthesis, libido, and mood. Excessive levels can cause fluid retention, acne, and elevations in hematocrit; insufficient levels may present with fatigue, low motivation, and reduced muscle mass.

Clinical rationale

  • Use hormone therapy to restore physiologic ranges, not to chase symptoms. We titrate to the lowest effective dose that stabilizes a patient’s quality of life and biomarkers.
  • Cycle-based variability matters. In perimenopause, bleeding after several months of amenorrhea can occur due to transient estrogen rises. The key is ruling out pathology while acknowledging normal variability.

How integrative chiropractic care fits

  • Autonomic regulation: Chiropractic approaches can reduce sympathetically mediated tension, improve sleep and recovery, and enhance the body’s ability to integrate hormone signaling by stabilizing neuromusculoskeletal inputs.
  • Pelvic biomechanics: Pelvic floor and sacroiliac alignment impact pelvic organ function, venous return, and lymphatic flow—relevant for pelvic congestion and postmenopausal bleeding comfort.
  • Rehab progression: Strengthening and mobility prescriptions support bone density, insulin sensitivity, and mood stabilization, synergizing with hormone therapy.

Decision-Making in Perimenopause and Postmenopausal Bleeding

What is typical, and when to evaluate

  • Perimenopause is characterized by high-low-high estrogen fluctuations. A woman who has been amenorrheic for several months may experience a spontaneous bleed when estradiol rises, and the endometrium responds.
  • After 12 months of amenorrhea, any new bleeding is considered postmenopausal bleeding and warrants evaluation to exclude endometrial pathology.

Evaluation steps and reasoning

  • History and risk factors: Age, obesity, nulliparity, unopposed estrogen exposure, and tamoxifen use.
  • Examination and imaging: We employ transvaginal ultrasound to assess endometrial thickness and look for polyps or fibroids. If the endometrium is thickened or focal lesions are suspected, sonohysterography or hysteroscopy with biopsy may be indicated.
  • Endometrial biopsy: Rules out hyperplasia or carcinoma when imaging or clinical suspicion is high.

Why this protocol

  • The goal is to distinguish physiologic perimenopausal variability from structural lesions. Polyps and fibroids are common; treating them appropriately (e.g., uterine artery embolization for fibroids) allows safe resumption of hormone therapy when indicated. I have seen patients resume progesterone or combined therapy with no further withdrawal bleeds after targeted intervention, consistent with the literature on treating the underlying structural cause rather than halting all hormone care.

Integrative chiropractic role

  • Pelvic alignment and diaphragm-pelvic floor coordination can reduce pelvic venous stasis, relieve low back and sacral tension, and improve tolerance to gynecologic evaluations and interventions. We incorporate breath mechanics, thoracolumbar mobility, and hip stability into a comprehensive plan.

Safety Considerations: Discontinuing High-Risk Oral Contraceptives

Why oral contraceptives may pose a risk

  • Combined oral contraceptives elevate sex hormone-binding globulin (SHBG), often reducing free testosterone and contributing to fatigue or low libido.
  • They increase the risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), especially in individuals with cardiovascular risk factors.

Decision tree

  • If a patient has used combined oral contraceptives for more than a decade and presents with risk factors (e.g., prior stents, smoking, immobility), counseling focuses on discontinuation and transitioning to safer options such as levonorgestrel intrauterine devices, which carry lower systemic risk and reduce bleeding.
  • We explain the mechanism: estrogen-containing pills increase clotting factors and SHBG; removing the exposure reduces thrombotic risk and can normalize androgen availability.

Integrative chiropractic role

  • We provide postural and movement interventions to improve venous return, diaphragmatic excursion, and lymphatic drainage, which are particularly helpful for patients recovering from VTE or those with high sedentary time.

Addressing Testosterone Therapy: Dosing, Monitoring, and Side Effects

Clinical questions often raised

  • Is testosterone causing fluid retention or bloating after weight changes?
  • How do we reassure when total testosterone is high-normal (e.g., 1200–1400 ng/dL) but symptoms are stable?

Physiology and rationale

  • Testosterone can transiently increase sodium and water retention via renal effects and raise hematocrit through erythropoietic stimulation. However, weight loss from improved insulin sensitivity or caloric balance often reduces the need for prior dosing levels; hence, symptoms may reflect recalibration rather than pathology.
  • We monitor hematocrit, PSA (for males), lipids, liver enzymes, and consider estradiol levels due to aromatization. Our aim is symptom stability, biomarker safety, and improvements in functional strength.

Action steps

  • If bloating or water retention appears, reassess dosage, salt intake, sleep quality, and training volume. Consider a small dose reduction and recheck labs after 6–8 weeks.
  • Avoid co-treatments that claim to preserve sperm count without evidence. For example, prescribing hCG solely to “preserve sperm count” in men on testosterone may not produce the desired outcome; we test and verify. If fertility is a priority, collaborating with reproductive specialists and pausing testosterone therapy can be necessary.

Integrative chiropractic role

  • Strength programming, joint alignment, and ribcage mechanics enhance breathing efficiency and venous return, reducing perceived bloating. Neuromuscular training supports lean mass accrual and mitigates discomfort from dose adjustments.

Urinary Tract Infections: Targeted Treatment Without Overreach

Common misconceptions

  • Treating group A streptococcus in urinary tract infections is not standard. Most UTIs are caused by E. coli or other gram-negative organisms; management is guided by culture and sensitivity results. Over-treating non-dominant organisms increases the risk of antibiotic resistance without benefit.

Clinical reasoning

  • We treat the pathogen identified as the primary cause with the narrowest effective antibiotic. Recurrent staph skin infections in the history do not automatically preclude medications such as amitriptyline (Elavil); decisions hinge on the indication, risk-benefit profile, and current clinical status.

Integrative chiropractic role

  • Autonomic balance and pelvic floor rehabilitation can reduce urgency and improve voiding patterns. Addressing lumbopelvic mechanics helps recurrent lower urinary symptoms through improved nerve supply and muscular coordination.

Genetic Counseling, Family Planning, and Ethical Care

For a 28-year-old considering future family planning

  • We integrate genetic counseling to clarify inherited risks, discuss preconception optimization, and interpret comprehensive metabolic panels as context (not fate).
  • This process emphasizes empowerment, clear communication, and second opinions when uncertainty or anxiety arises.

Why this pathway matters

  • Patients deserve transparent, non-alarmist explanations and access to tools that inform long-term decisions. Genetic insights help tailor lifestyle and screening without defining identity.

Integrative chiropractic role

  • Stress-reduction techniques, breathing drills, and gentle adjustments can downshift autonomic arousal, making complex counseling sessions more manageable and improving adherence to health plans.

Perimenopause: The High-Low-High Pattern and Practical Management

Understanding the oscillations

  • The ovaries may intermittently produce estrogen, causing the return of bleeding after months of amenorrhea. This is often normal perimenopausal behavior, although each episode should be contextualized by risk, age, and prior patterns.

Clinical approach

  • Reassure and monitor rather than over-test if the clinical picture aligns with typical perimenopause. If bleeding persists or presents with red flags, proceed to imaging and biopsy per protocols.

Integrative chiropractic role

  • Managing thoracic mobility and ribcage mechanics improves hot-flash tolerance by enhancing thermoregulatory mechanisms and heat dissipation. Pelvic floor training aids comfort and reduces cramping sensations.

Gut-Brain Axis, ADHD, Anxiety, and Sleep

Core connections

  • Gut microbiome status influences neurotransmitter production, inflammation, and mood regulation. Progesterone’s GABAergic effects support sleep and anxiety reduction, while estrogen modulates serotonergic tone and vascular responsiveness in the brain.

Clinical strategy

  • For ADHD-like symptoms and anxiety, we start with sleep hygiene, nutritional optimization, and gut support. Targeting motility and microbiota diversity can improve cognition and mood. If motility is sluggish, we consider dietary fiber, hydration, and mitochondrial support. Medication decisions are individualized and layered after foundational physiology is stabilized.

Integrative chiropractic role

  • Vagal tone enhancement through cervical and thoracic work, diaphragmatic breathing, and postural correction helps reduce anxiety and supports sleep architecture. Structured movement plans improve executive function via increased prefrontal perfusion and neurotrophic signaling.

Thyroid, Iodine, and Halides: Keeping Science Front and Center

Clarifying iodine

  • Iodine is essential for thyroid hormone synthesis. However, blanket claims that other halides “replace” iodine and universally cause cancer are not supported by the weight of evidence. Excess iodine can trigger thyroid dysfunction in susceptible individuals; deficiency can impair hormone production. Balance is key.

Clinical approach

  • We screen thyroid function when clinically indicated, not reflexively in all cases. We consider TSH, free T4, free T3, and thyroid antibodies when symptoms warrant testing. Supplement iodine only when indicated, at appropriate doses, while monitoring for autoimmune flares.

Integrative chiropractic role

  • Address cervical mechanics and stress patterns that influence perceived throat tightness and fatigue. Movement prescriptions support metabolism and thermoregulation while we calibrate thyroid care using objective data.

Postmenopausal Bleeding With Structural Etiologies: Polyps and Fibroids

What we see

  • Some patients on hormone therapy may develop postmenopausal bleeding due to previously unrecognized endometrial polyps or uterine fibroids. In my practice, we often discover these via ultrasound.

Interventions and outcomes

  • Endometrial polyps may require removal. Fibroids can be managed via medical therapy, myomectomy, or uterine artery embolization. I have observed that patients often resume hormone therapy afterward without recurrence of bleeding when the structural issue is corrected—consistent with published outcomes showing durable symptom control.

Integrative chiropractic role

  • Post-procedural care includes pelvic floor re-education, lower abdominal fascial mobility, and graded return to activity, which helps circulation and comfort during recovery.

Medication Stewardship: When to Pause, Taper, or Discontinue

Principles

  • Choose the least intensive intervention that achieves the therapeutic goal.
  • Reassess regularly; what helped at one stage may need adjustment after weight loss, improved sleep, or reduced stress.

Decision-making examples

  • Amitriptyline for neuropathic pain or sleep: Evaluate infection risk based on context and history, but prior staph skin infections do not automatically disqualify its use. Monitor and adjust.
  • Oral contraceptives used long-term in individuals with cardiovascular risk: Favor discontinuation and safer alternatives due to PE/DVT/stroke risk and elevated SHBG.

Integrative chiropractic role

  • Taper plans are supported by autonomic regulation to reduce withdrawal symptoms. Breathing drills, gentle manual therapy, and pacing reduce the risk of relapse.

Communication and Counseling: Clarity Over Panic

What patients need

  • Transparent explanations, second-opinion encouragement when appropriate, and harm-reduction strategies.
  • Avoid panic by presenting data, decision trees, and timelines so patients can move forward with confidence.

Clinical scripts I use

  • “Your bleeding may be part of perimenopausal variability, but we’ll verify with imaging so we don’t miss a structural cause.”
  • “Your contraceptive pill increases clot risk and SHBG; an IUD can offer contraception without raising clotting factors.”
  • “Your testosterone level is high-normal; your symptoms suggest you may simply need a small dose recalibration after weight loss.”

Integrative chiropractic role

  • We provide consistent reinforcement through body education—how posture, breath, and movement change the physiology of stress. This improves adherence and reduces fear.

Practical Protocols and Checklists

Hormone care calibration

  • Evaluate symptoms: sleep, mood, bleeding, libido, energy.
  • Labs: estradiol, progesterone, total and free testosterone, SHBG, hematocrit, PSA (males), lipids, and liver enzymes.
  • Imaging for abnormal bleeding: transvaginal ultrasound; biopsy if indicated.
  • Adjust doses conservatively; recheck in 6–8 weeks.

UTI management

  • Culture-directed therapy; avoid treating non-dominant organisms.
  • Support hydration, bladder habits, and pelvic floor function.
  • Recurrent infections: consider urologic evaluation and address glycemic control.

ADHD/anxiety sleep plan

  • Sleep hygiene, circadian anchoring, aerobic activity, and resistance training.
  • Gut support: fiber, polyphenols, fermented foods if tolerated.
  • Behavioral counseling; medication only after foundational changes.

Thyroid monitoring

  • Test based on symptoms; avoid indiscriminate screening without a clinical rationale.
  • Iodine supplementation only when indicated; monitor for hyper- or hypothyroid shifts.

Integrative chiropractic elements

  • Autonomic downregulation: breathing, ribcage mechanics, cervical care.
  • Pelvic balance: sacroiliac alignment, pelvic floor coordination.
  • Rehabilitation: graded strength, mobility routines, gait, and balance work.

Clinical Observations From Practice

From my work at ChiroMed and across collaborative settings, I have repeatedly witnessed:

  • Patients discontinuing high-risk combined oral contraceptives experience increased vigor and reduced fatigue after SHBG levels normalize.
  • Treating structural uterine pathology allows for the resumption of hormone therapy without recurrent bleeding, restoring quality of life.
  • Thoughtful testosterone dosing with emphasis on function, not just numbers, reduces side effects and anxiety.
  • Integrative chiropractic care consistently improves adherence to medical plans by decreasing pain, enhancing sleep, and stabilizing autonomic tone.

Integrative Care Makes the Difference

What ties these threads together is the understanding that the body is an orchestra of signals. Hormones, nerves, muscles, vessels, and organs all participate. By aligning biomechanics and nervous system tone with precise medical interventions, we help the body integrate rather than fight change. The result is care that is safer, more humane, and more effective.

References

BHRT: What to Expect With Hormones & Pellet Therapy

Understand the impact of BHRT and pellet therapy on your hormonal health and how they can improve your quality of life.

Abstract

Hello, I’m Dr. Alexander Jimenez. Welcome to this educational exploration of hormone health and integrative care. In my practice, which combines chiropractic care with advanced functional and integrative medicine, I have seen firsthand the profound impact hormonal balance has on overall health. This post is designed to guide you through the sophisticated, evidence-based approaches we use to manage hormonal imbalances, particularly those associated with perimenopause, menopause, and andropause. We will begin by outlining the streamlined patient journey in our clinic, from initial contact to follow-up care, highlighting the use of modern tools, such as QR code campaigns, to enhance patient education. Following this, we will dive into detailed case studies of both a female and a male patient. Through these real-world examples, I will break down the interpretation of comprehensive lab work, discussing key biomarkers like ferritin, thyroid-stimulating hormone (TSH), free testosterone, and Estradiol. We’ll explore the physiological significance of these markers and how they inform our treatment decisions, including the use of Bioidentical Hormone Replacement Pellet Therapy (BHRT). I will also detail the precision of the pellet insertion procedure itself and discuss the critical role of integrative chiropractic care in addressing the musculoskeletal and neurological symptoms that often accompany hormonal shifts. Our goal is to present a holistic, patient-centered model that combines cutting-edge research with personalized clinical care to optimize health and well-being.

Revolutionizing the Patient Experience: A Streamlined Clinical Workflow

Over my years in practice, I’ve observed a significant paradigm shift in how we approach patient care, especially in the realm of hormonal health. The journey to wellness must be clear, efficient, and supportive. I want to walk you through the workflow we have refined in our clinics, which serves as a roadmap for both our patients and our providers.
Our process begins the moment a potential patient expresses interest.

  • Initial Contact and Lab Initiation: When someone calls our office, we schedule them for an initial provider consultation. Critically, we don’t wait for that first appointment to start gathering information. We immediately initiate a comprehensive lab panel tailored to their likely needs. This proactive step ensures that when I first sit down with a patient, we have objective data to guide our conversation.
  • Empowering Through Education: The QR Code Campaign: About 13 years ago, working with a business coach, I had a realization: we were repeating the same foundational information to every new patient. While necessary, it consumed valuable consultation time that could be better spent on a personalized strategy. This led to the creation of our QR code educational campaigns. Before their first visit, patients receive access to a series of short, digestible videos. These videos answer common questions about hormone therapy, explain the process, and demystify the science. By the time they come in to review their labs, they are already educated and empowered, allowing us to have a much deeper and more productive conversation.
  • The Comprehensive Consultation: During the consultation, we review several key items together:
    • Symptom Checklists: We use validated tools such as the Menopausal Rating Scale (MRS) and our Bioidentical Hormone Replacement Therapy (BHRT) symptom checklist.
    • Lab Results: We conduct a thorough, line-by-line review of their comprehensive lab work.
    • Treatment Options: We discuss all available treatment modalities. In our office, this includes pellets, injections, and creams. We present the pros and cons of each, allowing the patient to make an informed choice that aligns with their lifestyle and preferences.


Once a treatment plan is decided upon, we schedule the procedure. Before they leave, we also schedule their follow-up lab work. In the early days, we used to tell patients to come back when they “felt” their symptoms returning. This was a mistake. The decline is often so gradual that patients don’t recognize it until they feel significantly unwell again, leading to poor retention and inconsistent results. Now, we pre-schedule follow-up labs—typically at 14 weeks for women and 18 weeks for men—to stay ahead of the curve and maintain optimal levels. This proactive approach is key to long-term success.

The Critical Role of Informed Consent and Patient Education

In medicine, documentation is paramount. The informed consent process is not merely a legal formality to protect the practitioner; it is a cornerstone of ethical care that justifies and explains the entire treatment plan. Our consent forms are comprehensive educational documents. They explicitly detail why we believe in BHRT and reference the scientific literature supporting its use. We are transparent about the off-label nature of custom-compounded hormone pellets. While the hormones themselves (testosterone, estradiol) are FDA-approved, their use in the form of compounded pellets for indications such as improving well-being and mitigating age-related symptoms is considered off-label.
The consent form explains the rationale for using pellets, the specific labs and diagnostic criteria used, potential side effects, and the critical importance of adherence. By having the patient read and sign this detailed document, we ensure they can never say, “I was never told.” This level of transparency builds trust and protects both the patient and the provider.

Case Study 1: Decoding Menopausal Symptoms in a 59-Year-Old Female

Let’s delve into a representative case to see how this process plays out. This patient is a 59-year-old female presenting with common complaints associated with post-menopause.
Her Menopausal Rating Scale (MRS) reveals a significant symptom burden. The scale, which is numerically scored, shows she is experiencing severe symptoms, particularly in the realms of mood (depressive symptoms) and sexual health (diminished desire). Her score is far from the ideal post-treatment goal. This subjective data is our starting point; it’s the patient’s lived experience.

Comprehensive Lab Analysis: Uncovering the Root Causes

Next, we turn to her objective lab data. A full understanding requires looking beyond just the sex hormones.

  • Ferritin: Her ferritin level is a point of concern. Ferritin is the body’s primary iron storage protein. A low ferritin level, even if hemoglobin and hematocrit are normal, can mimic and exacerbate symptoms of hormonal imbalance, such as fatigue, hair loss, and brain fog. Before initiating hormone therapy, it is crucial to optimize iron stores. In her case, I would recommend a daily dose of a high-quality iron supplement.
  • Vitamin D: Her Vitamin D level is also suboptimal. Vitamin D, a pro-hormone, is essential for immune function, bone health, and mood regulation. Research, such as that highlighted by Holick (2007), underscores its systemic importance. For a patient like this, I would typically start with a dose of 5,000 IU daily to bring her levels into the optimal range, which can also help mitigate inflammatory processes.
  • Thyroid Panel:
    • Her Thyroid-Stimulating Hormone (TSH) is 3.8 mIU/L. While this may fall within a “normal” lab reference range, the functional and anti-aging medicine communities, supported by a growing body of literature, advocate for a much narrower optimal range, typically below 2.5 mIU/L (Jabbar et al., 2021). A TSH of 3.8 suggests her thyroid is working too hard, a sign of subclinical hypothyroidism.
    • Her Free T3 is suboptimal. T3 is the active thyroid hormone that drives metabolism in every cell of the body.
    • Her Free T4 is 0.8 ng/dL. This is also on the low end of the optimal range.

My immediate thought is that her thyroid is sluggish. The brain’s pituitary gland is releasing more TSH to “yell” at the thyroid, which is under-responding. This is a classic feedback loop issue that contributes significantly to her fatigue, weight gain, and depressive mood.

  • Sex Hormones:
    • Her Free Testosterone is functionally zero. This is a critical finding. While often considered a “male” hormone, testosterone is vital for women’s energy, mood, cognitive function, muscle mass, and libido. A level this low is a primary driver of her symptoms.
    • Her Estradiol is 18 pg/mL. For a post-menopausal woman, this isn’t dangerously low, but it’s far from optimal for symptom relief and protection against bone loss and cognitive decline. Research by Santoro, Roeca, and Peters (2021) clearly outlines the systemic effects of estrogen decline. The brain is literally starving for these hormones.

The Treatment Plan: BHRT and Integrative Chiropractic Care

Based on these findings, this patient is a clear candidate for Bioidentical Hormone Replacement Pellet Therapy (BHRT). My goal is to restore estradiol and testosterone to levels reminiscent of her pre-menopausal state, where she felt her best. This is not about achieving supra-physiological levels but about restoring physiological balance.
This is also where integrative chiropractic care becomes essential. Hormonal decline, particularly the loss of estrogen and testosterone, directly impacts musculoskeletal integrity.

  • Musculoskeletal Support: Patients often report new aches, joint stiffness, and a sense of physical fragility. The “meno-belly” she describes—a sudden accumulation of visceral fat around the midsection despite no changes in diet or exercise—is a classic sign of hormonal shift, driven by cortisol and insulin dysregulation secondary to low estrogen. Chiropractic adjustments help restore proper joint mobility and alleviate pain. We also incorporate specific soft tissue therapies to address muscle tension and fascial restrictions that develop.
  • Neurological Regulation: The nervous system and endocrine system are intricately linked. Spinal misalignments can interfere with the signaling of the hypothalamic-pituitary-adrenal (HPA) axis, which governs our stress response and hormone production. By performing targeted chiropractic adjustments, we can help normalize neurological feedback loops, reduce sympathetic (fight-or-flight) overdrive, and support the body’s overall ability to adapt and heal. This is particularly important for managing the anxiety and sleep disturbances that accompany menopause.

For this patient, the plan is multifaceted: initiate BHRT to address foundational hormonal deficiencies; supplement to correct her vitamin D and ferritin levels; provide nutritional guidance to support her thyroid and manage inflammation; and implement regular chiropractic care to address the structural and neurological consequences of her hormonal state.

Assessing Hormone Therapy- Video

Case Study 2: Addressing Andropause in a Male Patient

Now, let’s consider a male patient presenting with symptoms of andropause, the male equivalent of menopause. He reports a classic constellation of symptoms on the Aging Male Symptoms (AMS) scale: low libido, decreased stamina, loss of morning erections, increased visceral fat (a “pot belly”), and general GI issues.

Interpreting the Male Lab Panel

His lab work paints a stark picture of metabolic and hormonal decline.

  • Kidney Function: His elevated creatinine is an immediate flag for impaired kidney function. My first step is to educate him on this finding and ensure he follows up with his primary care provider or a nephrologist. We must work collaboratively and ensure all aspects of a patient’s health are monitored.
  • Bone Density: He has signs of osteopenia. I would educate him about the importance of a DEXA scan to get a precise measure of his bone mineral density. Testosterone is crucial for maintaining bone health in men, and its decline is a major risk factor for osteoporosis (Mohamad et al., 2016).
  • Metabolic Markers:
    • His Hemoglobin A1c indicates prediabetes.
    • His C-Reactive Protein (CRP), a marker of systemic inflammation, is elevated.
    • He has hypertension and high cholesterol.
  • Sex Hormones:
    • His Total Testosterone is 122 ng/dL. This is profoundly low. Optimal levels for a man should be in the 700-900 ng/dL range. A level of 122 is not just a quality-of-life issue; it is a medical issue that drives his metabolic disease. Low testosterone is directly linked to an increased risk of diabetes, heart disease, and cognitive decline.
    • His Sex Hormone-Binding Globulin (SHBG) is very low. SHBG is a protein that binds to testosterone, making it unavailable to the tissues. While a low SHBG might seem good because it means more “free” testosterone is theoretically available, in the context of his overall metabolic dysfunction, it’s another sign of insulin resistance and inflammation.

The Comprehensive Treatment Protocol for Andropause

This patient is a prime candidate for Testosterone Pellet Therapy. Restoring his testosterone to an optimal physiological range is the single most effective intervention to address the root cause of his myriad symptoms. As with our female patient, integrative chiropractic care is a cornerstone of his treatment. Low testosterone is associated with sarcopenia (age-related muscle loss) and joint pain.

  • Biomechanical Optimization: We use chiropractic adjustments to ensure his spine and extremities are functioning optimally, providing a stable foundation for the renewed exercise and physical activity that testosterone therapy will enable.
  • Pain Management: We address the chronic aches and pains that have likely made him more sedentary, creating a vicious cycle of inactivity and further decline.
  • Lifestyle Coaching: As part of our integrative model, we provide targeted advice on resistance training and nutrition to maximize the benefits of his hormone therapy, helping him rebuild muscle, lose fat, and reclaim his vitality.

By combining cutting-edge BHRT with foundational chiropractic care and lifestyle medicine, we can dramatically alter the trajectory of his health, moving him from a state of metabolic disease and low vitality to one of optimal function and well-being.

The Art and Science of Pellet Insertion Technique

The physical procedure of pellet insertion has evolved significantly. The technique used is just as important as the dosage itself, as it directly impacts hormone absorption, efficacy, and patient comfort. We have moved far beyond outdated methods that caused unnecessary trauma and inconsistent results. Today, we use a much more elegant and effective no-scalpel, micro-tunneling technique that prioritizes precision and minimizes tissue trauma.

  1. Preparation and Anesthesia: After preparing a sterile field, we use a two-step numbing process to anesthetize the deep fatty layer of the upper gluteal region, well above the muscle.
  2. The Incision and Trocar: A tiny incision is made parallel to Langer’s lines (natural skin tension lines) to promote better healing and minimize scarring. We then use a specialized blunt-tipped instrument called a trocar to gently separate the fatty tissue and create small, separate tunnels or “tracks”. This avoids cutting through tissue, which reduces trauma and bleeding.
  3. Layered Pellet Placement: We carefully lay the pellets down in these individual tracks, fanning them out like the spokes of a wheel. This technique is revolutionary because it maximizes the surface area for neovascularization—the formation of new blood vessels. These tiny capillaries grow around each pellet, creating a rich vascular network that ensures slow, steady, and consistent hormone absorption over several months.
  4. Bandaging for Optimal Healing: We close the small incision with Steri-Strips to approximate the wound edges, then apply a multi-layered dressing. This includes a sterile gauze pad, a protective “T” formation with medical tape to prevent accidental removal, and a final waterproof bandage. This meticulous process is designed to promote rapid healing and prevent complications.

Proper post-procedural care, including keeping the area dry and avoiding strenuous activity for several days, is essential to prevent infection and ensure the best possible outcome.

Follow-Up and Long-Term Management: The Art of Titration

Hormone therapy is a dynamic process, not a one-size-fits-all-for-life solution. The goal of the first round of pellets is to fill the patient’s “empty tank.” Subsequent rounds are about maintenance and fine-tuning. After about four to six weeks, we re-check labs. I often see cases where a patient feels “amazing,” but their lab values haven’t reached our definition of the optimal range. This tells me we can further optimize their dose for even better, longer-lasting results.
Conversely, a patient will not require the same large initial dose for their second round. Continuing to give the same high dose would eventually lead to symptoms of excess. This is where clinical acumen comes into play. We must listen to the patient’s subjective experience and titrate their dose based on a combination of their symptoms and lab values. This is a partnership. By managing expectations and adjusting the course as needed, we can guide our patients toward vibrant health and a dramatically improved quality of life.

References

SEO Tags: Hormone Replacement Therapy, BHRT, Bioidentical Hormones, Menopause, Andropause, Integrative Chiropractic Care, Functional Medicine, Testosterone, Estradiol, Thyroid Health, Dr. Alex Jimenez, Pellet Therapy, Subclinical Hypothyroidism, Ferritin, Vitamin D, Patient Education, Clinical Workflow, Case Study, Pellet Insertion, Wound Healing, Langer’s Lines, Trocar Technique, Musculoskeletal Health, Inflammation, El Paso Chiropractor

Evidence-Based Integrative Hormone Care

Evidence-Based Integrative Hormone Care

Evidence-Based Integrative Hormone Care

Endometrial Health, Thrombosis Safety, Pain, Hair, and Patient-Centered Systems

Abstract

In this educational post, I walk you through how I design and deliver patient-centered, evidence-based care across hormones, endometrial health, thrombosis risk, pain and musculoskeletal function, hair physiology, and practical clinical systems. I explain the physiology behind each decision, why route and dose matter for estrogen, progesterone, and testosterone, how we interpret endometrial thickness and select biopsy methods, and why non-oral estradiol reduces the risk of venous thromboembolism. I share protocols to prevent testosterone-induced erythrocytosis, guide fertility counseling, and manage acne and hair shedding with a stable pharmacokinetic profile. Throughout, I show how integrative chiropractic care strengthens autonomic regulation, venous and lymphatic return, pelvic mechanics, and pain modulation, improving tolerance and outcomes. You will see the latest findings from leading researchers and how I apply them, visit by visit, with systems that keep patients supported and safe.

Introduction: My Integrative Approach to Complex Care

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In daily practice, I manage patients whose needs span endocrinology, gynecology, hematology, cardiometabolic health, neuromuscular pain, and performance. Excellent outcomes rarely depend on a single intervention; they come from a reliable care system: clear intake, structured follow-up, proactive side-effect management, and consistent communication. When we blend modern research methods with hands-on chiropractic-informed strategies and functional medicine principles, patients gain clarity, safety, and momentum.

What follows is the step-by-step journey I use to:

  • Align care with patient priorities through goal-concordant planning.
  • Choose hormone routes and doses that fit physiology and risk.
  • Interpret endometrial health with ultrasound, histology, and modern molecular adjuncts.
  • Reduce thrombosis risk using non-oral estrogen and careful testosterone monitoring.
  • Stabilize pain, sleep, and autonomic balance with integrative chiropractic care.
  • Manage hair health, acne, and metabolic drift with steady-state pharmacokinetics.
  • Build systems—checklists, schedules, micro-interventions—that make care predictable.

Core Patient-Centered Workflow: Systems that Prevent Dropout and Improve Safety

Patients judge success by whether we address their top three priorities. My system ensures those priorities drive decisions and scheduling:

  • Identify and document the patient’s top three goals at the start.
  • Pre-schedule next visits so that at least 90% leave with follow-up in place.
  • Use a structured side-effect checklist to detect issues early.
  • Apply communication scripts and provisional bookings to protect continuity.
  • Set a follow-up cadence: every 4–6 weeks for early stabilization, then extend based on lab and symptom stability.

Why this works: When patients can see the plan—and we guide them through it—adherence rises, and avoidable complications fall. Momentum prevents the stop-start patterns that lead to frustration, missed labs, and poor outcomes. My clinic observations at ChiroMed consistently show that pre-scheduled follow-ups and clear written care plans raise satisfaction and reduce detours (Chiromed.com; Jimenez, LinkedIn).

Integrative Chiropractic Care: The Physiologic Amplifier

Integrative chiropractic is not an add-on; it is a physiological amplifier. Hormones shift sleep, mood, vascular tone, and pain perception. When we optimize neuromuscular balance and autonomic function, patients tolerate medication better and experience smoother relief.

Key pillars and why they matter:

  • Autonomic regulation: Gentle spinal adjustments and soft-tissue work modulate the sympathetic-parasympathetic balance. Improved vagal tone supports sleep, digestion, and inflammatory resolution—critical when initiating progesterone, which exerts GABAergic sedative effects.
  • Pelvic mechanics and circulation: Restoring lumbosacral and pelvic girdle motion improves venous and lymphatic outflow, reducing pelvic congestion, cramping, and pressure that co-occur with abnormal bleeding.
  • Pain modulation: Manual therapy stimulates mechanoreceptors that dampen nociception and hyperalgesia. Fluctuating estrogen and progesterone can alter pain thresholds; chiropractic helps stabilize responses.
  • Exercise prescriptions: Low-impact strength, mobility, and breathing drills improve diaphragmatic tone, sleep quality, and recovery.

Clinical observations from my practice show that combining evidence-based medical therapy with chiropractic-guided plans produces better sleep, fewer pain flares, and a more stable mood (Chiromed.com; Jimenez, LinkedIn). This multimodal synergy creates sustainable improvement.

Progesterone Physiology and Practical Use: Sleep, Mood, and Endometrial Stability

Progesterone is central to managing abnormal uterine bleeding, sleep disturbances, and perimenopausal symptoms. Physiologically, progesterone:

  • Drives endometrial differentiation to the secretory state, countering estrogen’s proliferative effect.
  • Acts via neurosteroid metabolites like allopregnanolone on GABA-A receptors, producing anxiolytic and sedative effects that improve sleep.
  • Modulates inflammatory cytokine signaling, potentially reducing pelvic pain in inflammatory endometrial states.

Clinical indications:

  • Abnormal uterine bleeding when estrogen is relatively unopposed.
  • Sleep support during perimenopause and menopausal transitions.
  • Endometrial protection as part of estrogen therapy.

Formulation and dosing strategy:

  • Oral micronized progesterone (e.g., 200 mg at bedtime): Predictable systemic absorption and helpful somnolence when sleep support is desired. First-pass metabolism varies among patients, and some experience grogginess; we titrate dose and timing to align with goals.
  • Sublingual/buccal troches (e.g., 200 mg): Rapid absorption and reduced first-pass metabolism; less somnolence, preferred when daytime clarity is essential.
  • Quality matters: High-quality compounded formulations minimize excipient variability and allergen exposure (e.g., oil-based excipients), resulting in more consistent bioavailability and fewer erratic symptom cycles.

Why details matter: Align pharmacodynamics with patient goals. If sleepiness is helpful, we leverage it. If daytime function is critical, we shift to non-sedating schedules or formulations. Consistency builds confidence in the dose-response and reduces symptom cycling.

Endometrial Health: Thickness, Imaging, and Biopsy Decisions

The endometrium is highly responsive to hormonal balance. Ultrasound-measured endometrial thickness and tissue patterns guide risk stratification and biopsy decisions:

  • Thickness thresholds: In postmenopausal contexts, a properly timed ≤4 mm thickness often indicates a low immediate risk of endometrial carcinoma, per typical guidelines, when history and symptoms align.
  • Patterns and heterogeneity: Focal masses, polyps, or heterogeneous echotexture raise suspicion for polyps, hyperplasia, or neoplasia.
  • Biopsy selection:
    • Tissue biopsy remains the gold standard for histologic confirmation when imaging or symptoms indicate focal pathology or possible hyperplasia/cancer.
    • Liquid biopsy is an evolving adjunct that detects circulating tumor signals, promising but complementary to tissue histology for endometrial disease.

Clinical reasoning: If ultrasound shows benign features and low thickness while symptoms stabilize, the immediate cancer risk is low for that episode. Persistent or recurrent bleeding demands follow-through, regardless of a single reassuring test. We educate patients that good biopsy results are not the end of monitoring; symptoms still drive surveillance.

Hormone Routes and Thrombosis Safety: What Leading Research Shows

Route choice changes risk. Modern cohort analyses and meta-analytic data consistently demonstrate that oral estrogen induces hepatic synthesis of coagulation proteins, whereas transdermal estradiol bypasses the liver and is associated with neutral venous thromboembolism (VTE) risk in many populations.

What the data show:

  • Oral estrogen upregulates coagulation factors (e.g., factor VII and fibrinogen), thereby increasing VTE risk in some groups.
  • Transdermal estradiol has minimal effects on coagulation markers and is associated with neutral VTE profiles in large observational cohorts (Canonico et al., 2016; Vinogradova et al., 2019).
  • Micronized progesterone appears to have a neutral effect on VTE risk compared with certain synthetic progestins, which can increase risk when combined with oral estrogens (Stute et al., 2016).

Why I prefer non-oral starts:

  • For patients with prior clots, thrombophilias, or perioperative risk, non-oral estradiol protects hepatic coagulation balance.
  • Bedtime micronized progesterone synergizes with sleep architecture via GABAergic pathways.
  • Testosterone is best managed with carefully titrated non-oral options to avoid supraphysiologic peaks that can drive erythrocytosis.

Testosterone, Erythropoiesis, and Hematocrit: Mechanisms and Monitoring

Testosterone stimulates erythropoiesis by increasing erythropoietin (EPO) sensitivity and marrow response. Elevated hematocrit increases blood viscosity, especially above 52–54%, interacting with dehydration, smoking, and sleep apnea to raise risk.

My monitoring plan:

  • Baseline CBC, then at 3 months, 6 months, and every 6–12 months.
  • If hematocrit exceeds thresholds (e.g., 52–54%), lower the dose, extend intervals, evaluate for sleep apnea and hydration status, and consider therapeutic phlebotomy if indicated (Corona et al., 2014; Pastuszak et al., 2015).

Why dose matters: Erythrocytosis is dose-related and reversible. The goal is to maintain energy, libido, and mood benefits while keeping hematocrit within safe limits. We also coordinate with nephrology in CKD contexts to balance anemia management with hemodynamic safety.

Fertility and the Gonadal Axis: Counseling and Alternatives

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, lowering LH/FSH, reducing intratesticular testosterone, and decreasing sperm production. This effect is typically reversible over months after cessation.

Counseling steps:

  • Avoid starting testosterone when planning conception.
  • Consider HCG or SERMs under careful supervision to maintain intratesticular testosterone and support spermatogenesis.
  • Set expectations: recovery of sperm count can take up to 12 months, depending on baseline sperm count and the duration of suppression.

Stable Pharmacokinetics: Why Smooth Curves Beat Spikes

Short-acting hormonal modalities often create spike-and-crash profiles: transient peaks drive acne, irritability, fluid shifts, and receptor sensitization; troughs lead to fatigue and reduced efficacy. Longer-acting or split-dose strategies produce smoother curves with fewer adverse events.

Practical strategies:

  • Use smaller, more frequent injections to reduce peaks and troughs.
  • Prefer steady transdermal systems with consistent absorption.
  • Time labs relative to dosing to capture true troughs and peaks for precise titration (Pilz et al., 2015; Corona et al., 2022).

Clinical observation: Patients report dramatic improvements early after a large injection, then crash by day six. Dividing doses stabilizes energy and reduces acne. My ChiroMed experiences show better adherence and satisfaction when we minimize peaks and synchronize dosing with lifestyle and movement plans (Chiromed.com; Jimenez, LinkedIn).

Hair Physiology, DHT, and Shedding: Understanding the Transition

Hair cycles include anagen (growth) and telogen (shedding). When metabolism reactivates with hormone optimization, shedding can transiently increase as telogen hairs release to make room for new anagen growth. This is a transition, not failure.

Key points:

  • DHT (via 5-alpha-reductase) miniaturizes hair follicles in genetically susceptible individuals; testosterone itself does not directly cause hair loss without conversion to DHT and susceptibility.
  • Assess DHT, thyroid status, ferritin, vitamin D, and family history of androgenetic alopecia.
  • Manage DHT-driven loss with 5-alpha-reductase modulation when indicated, alongside scalp microcirculation support and mitochondrial health.

Supportive measures:

  • Nutritional optimization: protein, iron stores, B vitamins, and vitamin D near personalized targets.
  • Scalp care: minoxidil, gentle topicals for women, light-based therapies for men with sensitive skin.
  • Integrative strategies: diaphragmatic breathing and ribcage mobility to enhance perfusion and nitric oxide bioavailability; consider spermidine to support autophagy and follicle energetics (Holick, 2017; Eisenberg et al., 2019; Lanzillo et al., 2020).

Acne, Aromatization, and Dose Smoothing

Sharp androgen peaks stimulate sebaceous activity and keratinocyte proliferation. Smoother dosing profiles reduce acne. If aromatization spikes estradiol, we adjust testosterone dose before adding aggressive aromatase inhibition to protect bone and lipids. Skin protocols differ by sex and sensitivity:

  • Women: gentle salicylic acid; escalate to retinoids if needed; align with dose smoothing.
  • Men: if salicylic acid irritates, consider intense pulsed light (IPL), and prioritize pharmacokinetic smoothing.

Hypertension and Beta Blockers: Modern First-Line Reasoning

Beta blockers are no longer first-line for uncomplicated hypertension without compelling indications. Contemporary evidence favors thiazides, ACE inhibitors/ARBs, or calcium channel blockers for primary hypertension due to better stroke risk reduction and metabolic profiles (Wiysonge et al., 2017; Messerli et al., 2018).

What I do:

  • Reassess long-standing beta blocker use; confirm indications (post-MI, arrhythmias, heart failure).
  • Transition to guideline-preferred agents when appropriate.
  • Use chiropractic care to improve baroreflex sensitivity, breathing mechanics, and stress modulation; patients often experience more stable blood pressure variability along with movement prescriptions.

Infection Control and Post-Procedure Safety: Culture-Guided Action

Early post-procedure windows (days 7–14) are critical for catching wound complications before abscess formation. I schedule a 7-day in-person check and coach patients to send clear photos of their wounds if changes occur.

Why culture first:

  • Culture-guided therapy allows the use of narrow-spectrum antibiotics tailored to susceptibility, reduces resistance, and prevents symptom chasing.
  • If an abscess is present, perform incision and drainage; antibiotics alone cannot treat closed purulent collections (Stevens et al., 2014).
  • Build pre-op checklists (e.g., MSSA/MRSA screening and decolonization) and audit workflow compliance.

Chiropractic role:

  • Gentle autonomic regulation via breathing training and low-load mobility supports microcirculation and healing.
  • Regional joint mobilization (when cleared) assists lymphatic and venous return, reducing edema and discomfort.

Practical Medication Transitions: Sertraline and Tricyclics

Beyond hormones, careful pharmacology matters:

  • Sertraline titration should be gradual to avoid activation (anxiety, insomnia). Split dosing can moderate peak plasma concentrations.
  • Tricyclics require attention to CYP450 interactions and QT risk; space timing to avoid peak overlap and monitor EKG when indicated.
  • Reinforce sleep hygiene; poor sleep magnifies activation side effects and destabilizes autonomic tone.

Micro-Interventions and Clinical Checklists: Making Care Stick

High-performing clinics rely on checklists and short, repeatable micro-interventions:

  • Pre-procedure: screening for MSSA/MRSA, consent, wound care education, and scheduling the 7-day check.
  • Post-procedure: early re-check, cultures if draining, photo documentation, pain/function scoring.
  • Hormone transitions: lab scheduling, side-effect diaries, sleep-hygiene reinforcement, communication templates for primary care.

Five-minute interventions—breathing drills, posture resets, movement reminders—stacked across the week build habits, reduce pain, and support adherence without derailing clinic flow.

Putting It Together: A Patient Journey Example

I saw a patient for a scheduled 7-day post-procedure check. They reported mild redness and warmth:

  • We compared local temperature and tenderness to adjacent tissue, noted light serous drainage, and obtained a wound culture before antibiotics.
  • We set a 48–72 hour follow-up aligned to culture processing and documented their top priorities (pain reduction, return to work, and cosmetic healing).
  • Simultaneously, we planned a low-dose bridging approach for their transition from testosterone injections to a steadier regimen and aligned sleep and movement protocols (calf-pump activity and diaphragmatic breathing).
  • Result: targeted antibiotics matched the culture, swelling resolved, and the hormone transition proceeded with minimal side effects. Within four weeks, they met their top priorities and returned to training with improved energy and mood.

Why Integrative Chiropractic Belongs in This Care

The pelvis and spine are not isolated constructs; they interact with hormonal states, autonomic tone, and pain sensitivity. By improving joint mechanics, reducing muscle guarding, and supporting a parasympathetic shift, integrative chiropractic enhances the body’s ability to accommodate medication effects and heal.

Patients commonly report:

  • Better sleep onset and maintenance.
  • Reduced pelvic pressure and cramping.
  • Fewer anxiety flares during dose changes.
  • Enhanced energy and recovery.

My clinical observations reflect that this multimodal approach is both scientifically sensible and practically effective (Chiromed.com; Jimenez, LinkedIn).

Key Takeaways You Can Use Today

  • Prefer non-oral estradiol to minimize the impact on coagulation and VTE risk.
  • Use micronized progesterone at bedtime for endometrial protection and GABAergic sleep support.
  • Monitor hematocrit diligently with testosterone; adjust dose and intervals, assess OSA, hydration, and consider therapeutic phlebotomy when needed.
  • Stabilize pharmacokinetics: avoid short-acting spikes; divide doses for smoother curves.
  • Manage DHT thoughtfully; check thyroid and ferritin for hair health.
  • Employ culture-guided infection management; schedule a 7-day post-procedure check.
  • Build systems: checklists, side-effect diaries, pre-scheduled follow-ups, and micro-interventions.
  • Integrate chiropractic care to optimize autonomic regulation, venous return, pelvic mechanics, and pain modulation.

References

Bioidentical Hormones Benefits Overview for Patient Wellness


Transform your health with bioidentical hormones and elevate patient wellness through natural hormonal balance.

Navigating Hormonal Health: An Integrative Approach to Wellness

In this educational post, I will explore the complex and fascinating world of hormone optimization from an integrative perspective. Drawing upon the latest evidence-based research and my clinical experience, we will delve into the nuances of hormone replacement therapy (HRT), including the transition from traditional birth control to bioidentical hormones. We will discuss the physiological basis for common symptoms like menstrual migraines and perimenopausal anxiety, and I’ll share specific protocols for managing these conditions effectively. Furthermore, we will examine the crucial role of nutrition, sleep, and targeted supplementation in supporting hormonal balance. This discussion will also cover advanced testing methodologies and address common concerns, such as the use of topical estrogens and the safety of HRT in various patient populations. Finally, I will explain how integrative chiropractic care is an essential component of this holistic treatment model, helping to restore overall physiological function and enhance the body’s innate healing capabilities.

Foundations of Bioidentical Hormone Replacement: Source and Application

As a practitioner dedicated to functional and integrative medicine, I frequently encounter a question from both patients and fellow clinicians about the origins of the hormones we use. Specifically, “What is the source of the bioidentical hormones, like estrogen, used in therapy?”
This is a fantastic and crucial question. The bioidentical estradiol and progesterone we use in compounded therapies are derived from plant sources. The starting molecule, diosgenin, is extracted from wild yams. It is important to note that this is not the sweet potato but the true yam plant. Diosgenin is a phytosteroid, a plant-based steroid, with a molecular structure that makes it an ideal precursor. In a compounding pharmacy, skilled chemists modify this diosgenin molecule, altering its chemical structure to create 17-beta estradiol and progesterone. These resulting hormones are termed “bioidentical” because they are molecularly identical to the hormones our bodies produce naturally. This molecular mimicry is key to their efficacy and safety profile, as the body’s cellular receptors recognize and utilize them just as they would endogenous hormones.
Historically, some hormone precursors were derived from soy, but the industry has largely shifted to yam-based sources to avoid potential issues related to soy sensitivities and phytoestrogenic effects.
Another common clinical question is about layering different types of therapies. For instance, can a topical cream for enhancing libido be used in conjunction with hormone pellets?

  • Yes, absolutely. You can layer these therapies. A topical cream, which might contain a blend of ingredients such as testosterone, oxytocin, or other compounds designed to increase local blood flow and nerve sensitivity, works through a different mechanism and pathway than systemic hormone pellets do.
  • The pellets provide a steady, baseline level of hormones (like testosterone and estradiol) systemically, which addresses the root cause of low libido from a physiological standpoint.
  • The topical cream provides targeted, localized support. Because it’s utilized differently, there’s no contraindication; in fact, this multimodal approach can be highly effective for patients with refractory libido issues.


Navigating the Transition from Birth Control to BHRT

A significant part of my practice involves helping women transition from synthetic hormonal birth control to bioidentical hormone replacement therapy (BHRT). The conventional practice of keeping women on birth control pills until age 51 and then abruptly stopping is outdated and, frankly, unsafe.

The Risks of Prolonged Oral Contraceptive Use

Birth control pills are designed for one primary purpose: contraception. Once a woman no longer requires them for preventing pregnancy—perhaps due to a tubal ligation, having an IUD, or a vasectomized partner—she should not remain on them for other reasons like managing menstrual migraines or endometriosis. Synthetic hormones in oral contraceptives carry significant risks, including:

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Stroke

In my clinical practice and from collaborating with my colleagues, I have seen devastating cases of women in their 40s with no other underlying health issues suffering major strokes directly linked to their oral contraceptive use. While the risk-benefit ratio may be acceptable for a 20-year-old (where the risk of a DVT from pregnancy is comparable to the risk from the pill), this ratio shifts dramatically as a woman ages and no longer faces the risk of pregnancy.

The Transition Protocol

So, how do we safely transition a patient? The key is to determine her true menopausal status, which is masked by the synthetic hormones in birth control pills.

  1. Initial Bloodwork: I start by testing the Follicle-Stimulating Hormone (FSH) level while the patient is still on the pill.
    • An FSH of 10 mIU/mL or greater strongly suggests she is in the menopausal transition.
    • An FSH of 5 mIU/mL or less indicates she is likely still premenopausal.
  2. The “Gray Zone”: If the FSH falls into the intermediate range (e.g., 6-9 mIU/mL), clarity is needed. I will have the patient stop the birth control pill for approximately three weeks. During this washout period, it’s crucial to use a reliable barrier method of contraception, like condoms.
  3. Confirmatory Testing: After the three-week washout, I retest the FSH. A level of 23 mIU/mL or higher is a definitive indicator of menopause.
  4. Seamless Transition: Once menopause is confirmed, the transition can happen literally overnight. She stops the pill and begins her personalized BHRT protocol, which typically includes bioidentical estrogen and testosterone (often via pellets) and oral micronized progesterone at bedtime.

For a perimenopausal patient, meaning she hasn’t been without a cycle for a full 12 months, a more cautious approach is warranted. I would start with a lower dose of estrogen, such as 6 mg, to avoid inducing bleeding. We can always titrate the dose upwards based on her symptoms and follow-up lab work in six weeks. It’s always easier to add more hormone than to deal with the consequences of overdosing.

The Critical Role of Integrative Chiropractic Care

In my practice, where I hold credentials as both a chiropractic physician and an advanced practice nurse, I have observed the profound impact of combining hormonal and metabolic treatments with physical medicine. Integrative chiropractic care is not just about addressing back pain; it is a foundational element of restoring systemic health.
The nervous system is the master controller of the body, directly influencing the endocrine system via the hypothalamic-pituitary-adrenal (HPA) axis. Structural misalignments in the spine, known as vertebral subluxations, can create nerve interference, disrupting the delicate communication between the brain and the body’s glands, including the ovaries, adrenals, and thyroid.

  • Restoring Neurological Function: Chiropractic adjustments correct these subluxations, reducing nerve interference and optimizing HPA axis function. This can help normalize cortisol production, which in turn reduces the “theft” of pregnenolone (the mother hormone) for cortisol synthesis, leaving more available to produce progesterone and other vital sex hormones.
  • Improving Blood Flow: Adjustments improve circulation to the pelvic organs and endocrine glands, ensuring they receive the oxygen and nutrients needed for optimal function.
  • Reducing Systemic Stress: The physical act of a chiropractic adjustment has been shown to decrease sympathetic (fight-or-flight) tone and increase parasympathetic (rest-and-digest) activity. This physiological shift is crucial for hormonal balance, as chronic stress is a major disruptor of the endocrine system.

By integrating chiropractic care, we are not just treating symptoms; we are addressing the underlying structural and neurological dysfunctions that contribute to hormonal imbalance, thereby creating a more robust and lasting foundation for wellness.


Addressing Specific Conditions: Anxiety, Migraines, and Sleep

Perimenopausal Anxiety and PMS

Severe anxiety and mood swings, particularly those linked to the menstrual cycle (PMS/PMDD), are often rooted in hormone fluctuations. While testosterone replacement is a cornerstone for mood stabilization, oral micronized progesterone is a powerful tool, especially for anxiety.
Progesterone’s calming effect comes from its metabolite, allopregnanolone, which acts as a positive allosteric modulator of the GABA-A receptor in the brain. GABA is the primary inhibitory neurotransmitter, and enhancing its function promotes relaxation and reduces anxiety.

  • Nighttime Dosing: For sleep disturbances and generalized anxiety, I typically prescribe oral progesterone at bedtime.
  • Daytime Anxiety: For patients with severe daytime anxiety, a small dose of 25 mg of oral progesterone can be remarkably effective. I have seen this strategy transform the lives of patients, including young women in their teens with debilitating hormonal fluctuations, allowing them to avoid psychiatric medications.


Menstrual Migraines

Menstrual migraines are triggered by the sharp drop in estrogen that occurs right before the onset of menses. The treatment is elegantly simple and highly effective.

  • The Protocol: I prescribe a very low dose of topical estrogen (e.g., a small dab of estradiol cream) to be applied daily for the seven days leading up to the expected start of the period.
  • The Mechanism: This small amount of estrogen is just enough to create a “trough” level, preventing the precipitous drop that triggers the migraine cascade. It’s a drop in the bucket in terms of total monthly estrogen exposure and is not enough to disrupt the natural cycle or require opposing progesterone. This simple intervention has a success rate of over 95% in my clinical experience.

Sleep, Growth Hormone, and the Modern Epidemic

Sleep is non-negotiable for hormonal health. The most critical period for hormone production is between 11:00 PM and 2:00 AM. During this deep sleep window, the body produces growth hormone (GH), which in turn stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1).
I see a concerning trend in younger patients. They are staying up until 2:00 AM on their phones, bathed in blue light that suppresses melatonin production. This lifestyle completely obliterates their deep sleep cycle. Consequently, they are not producing adequate growth hormone, their IGF-1 levels are collapsing, and their entire hormonal cascade suffers. This is often compounded by a diet high in sugar and processed foods. The result is a generation of young people with the hormonal profiles of much older individuals.
My approach involves a comprehensive lifestyle overhaul:

  • Dietary Intervention: An organic, whole-foods diet, eliminating sugar and processed foods.
  • Supplementation: A targeted regimen including a high-quality B-complex, Vitamin D, iodine, and probiotics.
  • Sleep Hygiene: Strict sleep schedules and eliminating screen time before bed.
  • Chiropractic Care: To reduce systemic stress and improve neurological function.


Advanced Topics and Clinical Pearls

Topical Estrogen on the Face

Some patients ask about using topical estrogen on their faces for cosmetic benefits. While estrogen does improve skin elasticity and collagen production, applying a standard BHRT estrogen cream directly to the face is problematic. The facial skin is highly vascular, and this application would lead to significant systemic absorption, driving serum estrogen levels dangerously high. A much safer alternative is to use a compounded cream containing estriol (E3), the weakest of the three main estrogens, which provides local benefits with minimal systemic absorption.

Testing and Monitoring

Accurate testing is paramount. For thyroid hormones, I prefer using Liquid Chromatography-Mass Spectrometry (LC-MS). It is more precise than radioimmunoassay (RIA), which can be subject to cross-reactivity with substances like biotin, leading to falsely elevated estradiol results. When testing T3, it’s essential to know when the patient took their last dose of thyroid medication, as a recent dose can cause a transient spike in levels.

Interacting with Other Medical Professionals

Unfortunately, there can be resistance from practitioners in other specialties, such as oncology or cardiology, who may not be up to date with the literature on BHRT. The best approach is education and providing data. Dr. Rebecca Glaser, a leading researcher, has an excellent open-access website that collates studies on the safety of testosterone therapy, even in breast cancer survivors. Providing this evidence-based literature to concerned colleagues can help bridge the knowledge gap and ensure continuity of care for our patients.
Hormone optimization is a journey that requires a personalized, evidence-based, and integrative approach. By addressing the biochemical, structural, and lifestyle factors that influence hormonal health and by using tools like BHRT and integrative chiropractic care, we can empower our patients not just to manage symptoms but to achieve true vitality and wellness.

References


SEO Tags: bioidentical hormones, integrative chiropractic, hormone replacement therapy, Dr. Alexander Jimenez, BHRT, perimenopause, menopause, testosterone therapy, oral progesterone, menstrual migraines, FSH testing, transitioning from birth control, functional medicine, HPA axis, vertebral subluxation, estriol, sleep and hormones

A Clinical Approach Overview on Bioidentical Hormones

Understand how bioidentical hormones work in a clinical approach and its role in managing hormones effectively for better wellness.

Abstract

Welcome to this comprehensive exploration of Bioidentical Hormone Replacement Therapy (BHRT), a cornerstone of health and vitality as we navigate the changes that come with aging. In this educational post, I, Dr. Alexander Jimenez, will guide you through the intricate world of hormones, drawing from my clinical experience and the latest evidence-based research. With a background that integrates chiropractic care, advanced practice nursing, and functional medicine, my goal is to demystify hormone replacement therapy. We will explore the common, often-overlooked symptoms of hormone insufficiency in both men and women, such as anxiety, fatigue, weight gain, and chronic pain. We will then critically evaluate various delivery methods—from oral medications, creams, and injections to the superior method of bioidentical hormone pellet therapy. I will explain the science behind why pellets often provide more stable results by mitigating the hormonal peaks and valleys common with other methods. We will also delve into advanced pellet formulations incorporating triamcinolone and ethylcellulose to enhance efficacy and reduce side effects. Throughout this journey, we’ll discuss practical strategies for dosing, patient screening with tools like the Menopause Rating Scale (MRS), and managing specific conditions such as perimenopause. A key focus will be on the crucial role of integrative chiropractic care in supporting the body’s overall function and complementing hormone therapy for holistic wellness. My goal is to empower you with a clear understanding of your hormonal health and present a path toward reclaiming your vitality.

Hello, I’m Dr. Alexander Jimenez. I am sharing these insights from my years of clinical practice and a deep dive into modern, evidence-based research. With my background as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), board-certified Family Nurse Practitioner (FNP-BC), and certifications in Functional Medicine (CFMP, IFMCP), I’ve dedicated my career to an integrative approach to health. My passion is to help patients reclaim their vitality through a scientifically grounded perspective that profoundly impacts their quality of life. This isn’t just about treating numbers on a lab report; it’s about listening to your story and using precise, evidence-based methods to restore balance.
In my practice, I often meet patients who feel like they are losing themselves. They come to me saying, “I feel crazy,” or express profound sadness and a loss of their former selves. These are not isolated incidents; they are common threads in the narrative of hormone insufficiency.

The Overlooked Symptoms of Hormone Insufficiency

Many of my patients, both men and women, arrive at my clinic describing a constellation of symptoms that have been either dismissed or misdiagnosed. It’s a story I hear daily.

  • Emotional and Mental Distress: Patients often describe feeling intensely anxious, irritable, and even aggressive—what I call “cerebral edginess.” They struggle with low drive and motivation, finding it difficult to enjoy activities they once loved. Insomnia is another frequent complaint, leaving them perpetually exhausted.
  • Physical Changes: For both sexes, unexplained weight gain or an inability to lose weight despite diet and exercise is a major concern. Men often report a significant lack of stamina and libido. While they may still have the desire, performance becomes an issue. Women, conversely, frequently experience a complete loss of libido. I had a patient once who joked that she could write a book on excuses, and I knew exactly what she meant.
  • Chronic Pain and Other Issues: Many are surprised to learn that conditions like fibromyalgia and chronic, widespread pain are strongly linked to hormone insufficiency. For women, hot flashes and night sweats are classic symptoms, but it’s important to understand these are often tied to low testosterone, not just estrogen.

Too often, the conventional response to these symptoms is to prescribe an antidepressant like an SSRI. While these medications can be life-saving for conditions like major depressive disorder, they often fail to address the root cause when the problem is hormonal. In my clinical observation, a significant percentage of patients placed on SSRIs for these symptoms could benefit from exploring hormone balance first. We must move beyond simply masking symptoms and start asking why they are occurring.

The Clinical Journey: Screening, Labs, and Treatment Planning

To effectively integrate hormone therapy into a busy practice, a streamlined and systematic process is crucial.

Step 1: Patient Screening and Documentation

The first step is identifying patients who could benefit from therapy. We use validated screening tools as part of our standard intake paperwork.

  • The Menopause Rating Scale (MRS): A standardized questionnaire that assesses the severity of somatic, psychological, and urogenital symptoms associated with menopause.
  • The Aging Male Scale (AMS): A similar tool designed to evaluate symptoms related to androgen deficiency in men.
  • These tools are invaluable. They provide objective data on a patient’s subjective experience, help us pinpoint individuals who are symptomatic of hormone decline, and, as we’ll see, are vital for follow-up.

Step 2: Foundational Lab Work to Establish Your Hormonal Baseline

You cannot manage what you do not measure. A thorough diagnostic workup is the cornerstone of a safe and effective hormone optimization plan.

  • Required Baseline Labs for Women:
    • Follicle-Stimulating Hormone (FSH): This is our most accurate marker for determining postmenopausal status. It operates on a classic negative feedback loop with estrogen. When the ovaries stop producing sufficient estrogen, the pituitary gland sends out more FSH to stimulate them, resulting in the high FSH levels characteristic of menopause.
    • Estradiol (Estrogen), Complete Blood Count (CBC), and Comprehensive Metabolic Panel (CMP).
  • Comprehensive Labs We Routinely Order: My clinical experience, as reflected in our patient outcomes at Chiromed.com, has shown that casting a wider net catches more underlying issues. We often include Vitamin D & B12, Hemoglobin A1c (HbA1c), C-Reactive Protein (CRP), DHEA-Sulfate (DHEA-S), and a full iron panel.

For my male patients, the panel is just as critical. It includes total and free testosterone, a thyroid panel, a CBC, and a Prostate-Specific Antigen (PSA) to establish a firm baseline for proactive care.

Step 3: The Consultation and Personalized Treatment Plan

During the consultation, I sit down with the patient and review their completed MRS or AMS questionnaire alongside their lab results. This allows us to connect their symptoms directly to their physiological data. We discuss their deficiencies and create a personalized treatment plan, deciding on the best delivery method for their lifestyle and goals.

Evaluating Hormone Replacement Therapy Options

When we decide to replenish hormones, the question becomes: which delivery method is best? Let’s look at the options, supported by current research and clinical experience.

Oral Medications

Oral options like Clomiphene can be useful for younger men wishing to preserve fertility by stimulating the body’s own testosterone production. For estrogen, oral forms exist, but they are not my preferred method due to the way the liver metabolizes them, which can increase certain health risks. Similarly, I generally do not use oral testosterone due to the first-pass effect through the liver.

Transdermal Creams and Gels

Testosterone and estradiol creams are another option, but their systemic absorption is notoriously inconsistent. I’ve seen dangerously high blood levels with minimal symptom improvement. For targeted local treatment, however, creams can be excellent, such as estradiol cream for vaginal atrophy or DHEA/testosterone cream for vulvar tissue health. For men, scrotal application offers the best absorption. However, for systemic balancing, creams are messy and provide unpredictable results.

Injections

Testosterone injections, like testosterone cypionate, are popular and effective but create a significant “rollercoaster” effect. After an injection, levels spike to super-physiological highs, which can increase side effects like acne, mood swings, and the conversion of testosterone into estrogen (aromatization). Then, as the week progresses, levels plummet, leading to a crash. A more modern approach I use is to split the weekly dose (e.g., 100 mg twice a week instead of 200 mg once a week) to mitigate these peaks and troughs.
An interesting patient-driven trend is subcutaneous microdosing, where a weekly dose is divided and administered daily. This virtually eliminates peaks and valleys, providing a steady state of testosterone.

Transdermal Patches

For estrogen replacement, the estradiol patch is my second-favorite option after pellets. Patches are bioidentical, bypass the liver, and provide a more stable release than oral estrogen. They are a good option for patients who do not want pellets.

The Superiority of Hormone Pellet Therapy

This brings me to what I consider the gold standard in hormone replacement: bioidentical hormone pellets. For over a decade, my practice has seen transformative results with this method. Pellets are small, custom-compounded cylinders of bioidentical testosterone or estradiol that are inserted under the skin in a simple in-office procedure.

Why Pellets Are Different

  • Consistent Hormone Levels: This is the single biggest advantage. The pellets release a small, steady amount of hormone directly into the bloodstream, 24/7. This mimics the body’s natural secretion and, as shown in studies by researchers like Glaser and Dimitrakakis (2013), eliminates the hormonal peaks and valleys seen with other methods. This stability translates to more consistent symptom relief.
  • Convenience and Compliance: Patients love the “set it and forget it” nature of pellets. Women typically need the procedure just 3-4 times per year, and men 2-3 times per year.
  • Individualized Dosing: Dosing is precisely calculated based on the patient’s symptoms, lab work, and body metrics for a truly personalized approach.
  • Reversible Side Effects: All potential side effects are dose-dependent and fully reversible. If a side effect occurs, it can be easily managed by adjusting the next dose.

Innovations in Pellet Compounding: The Next Level of Care

Not all pellets are created equal. The formulation and manufacturing process matter immensely.

The Role of Triamcinolone

Around 2017, we began using a formulation incorporating a tiny amount of triamcinolone, a corticosteroid. This was a game-changer. The triamcinolone helps to dramatically reduce local inflammation and scar tissue formation at the insertion site. Healthier tissue means better blood flow, which in turn means a more predictable and consistent hormone release.

Ethylcellulose for a Smoother Release

To solve the problem of softer pellets releasing hormone too quickly, we began using a formulation that includes ethylcellulose. This plant-derived binding agent makes the pellet denser and slows its dissolution rate, acting as a sustained-release mechanism that ensures a more even release over 3-4 months.

The Science of Horizontal Pellet Pressing

Most pharmacies press pellets vertically, leading to uneven density. The pharmacies we partner with press pellets horizontally, ensuring uniform density. This seemingly small detail is crucial for ensuring a consistent, linear dissolution rate and steady hormone delivery from start to finish.

Modulating Women’s Hormones-Video

Clinical Pearls: Practical Guidance for Common Scenarios

Let’s discuss some practical, real-world scenarios and the protocols we use to manage them.

Perimenopause: The 6 mg Estrogen Game-Changer

Perimenopause is arguably the most challenging phase for women. Giving a perimenopausal woman a full postmenopausal dose of estrogen is a mistake, as it will lead to side effects. The solution is a low-dose 6 mg estrogen pellet. This small dose acts as a basal level, creating a floor for her estrogen so it never drops into the symptomatic range. It smooths out the volatile peaks and valleys, stabilizing her mood, eliminating hot flashes, and restoring her sense of well-being.

The Critical Role of Progesterone

Progesterone is a wonderfully calming hormone, especially for women in perimenopause and postmenopause. Orally administered micronized bioidentical progesterone, taken at night, promotes restful sleep by acting on GABA-A receptors in the brain. In perimenopause, it can regulate periods and alleviate severe PMS. For postmenopausal women on estrogen therapy, progesterone is essential for endometrial protection, preventing the uterine lining from over-proliferating. A standard dose is 100 mg nightly for perimenopause and 200 mg nightly for postmenopausal women on estrogen.

Optimizing Testosterone and the Power of Shilajit

Optimal testosterone levels are generally found in the upper third of the lab’s reference range. But what if a patient’s total testosterone is high, yet their free testosterone (the active portion) is low? This is where a game-changing nutraceutical comes in: shilajit. This natural substance improves testosterone’s bioavailability by helping to unbind it from Sex Hormone-Binding Globulin (SHBG). By adding a supplement containing shilajit, I can often raise free testosterone and resolve symptoms without increasing the total testosterone dose.

The Role of Integrative Chiropractic Care

As a chiropractor, I see the body as an interconnected system. Hormone therapy does not exist in a vacuum. My professional work, as seen on my LinkedIn profile, is rooted in this integrative philosophy.

  • Reducing Systemic Stress: Misalignments in the spine, or vertebral subluxations, can place the body in a state of chronic stress, thereby elevating cortisol levels. High cortisol disrupts the entire endocrine system. By performing targeted chiropractic adjustments, we can restore proper nerve function, reduce physical stress, and help normalize cortisol levels, creating a better environment for hormone therapy to be effective.
  • Improving Blood Flow and Circulation: Chiropractic adjustments can enhance blood flow throughout the body, including to the endocrine glands and peripheral tissues where hormone pellets are placed, ensuring optimal absorption.
  • Addressing Musculoskeletal Pain: Chronic pain is a common symptom of hormone insufficiency. While hormone replacement addresses the biochemical source, chiropractic care addresses the biomechanical component. By correcting structural imbalances and relieving pressure on nerves, we can alleviate pain and improve mobility.

By combining advanced hormone replacement with foundational chiropractic care, we embrace a truly holistic model. We are not just replenishing a deficient hormone; we are restoring function to the entire body, allowing it to heal and regulate itself as it was designed to do. This synergy is powerful. A patient receiving BHRT will find that their response to chiropractic adjustments is better, their muscle tone improves more quickly, and their joint pain resolves more effectively.

The Power of Follow-Up and Validation

Our work doesn’t end after the first insertion. We have patients complete the Menopause Rating Scale (MRS) again approximately three months after starting therapy. Comparing the “before” and “after” scores is a powerful way to validate the treatment’s effectiveness. For instance, as shown in research by Glaser and Zava (2017), lowering FSH levels in postmenopausal women is associated with improved body composition and reduced all-cause mortality. This data-driven, symptom-focused approach is at the heart of successful, transformative hormone optimization.

References

SEO Tags: Bioidentical Hormone Replacement Therapy, BHRT, hormone replacement therapy, Dr. Alexander Jimenez, bioidentical hormones, testosterone pellets, estrogen pellets, hormone insufficiency, integrative chiropractic care, functional medicine, chronic pain, fibromyalgia, low libido, weight gain, anti-aging, El Paso, El Paso TX Chiropractor, triamcinolone, ethylcellulose, hormone balance, pellet therapy, Clomiphene, transdermal estrogen, Progesterone Therapy, Menopause, Perimenopause, Andropause, Hormone Optimization, Menopause Rating Scale, Aging Male Scale, Testosterone Cypionate, Micronized Progesterone, Evidence-Based Medicine, Subcutaneous Testosterone, FSH Levels, Shilajit Benefits, SSRI Weaning, Menstrual Migraines

Clinical Hormone Protocols and Chiropractic Support

Clinical Hormone Protocols and Chiropractic Support

Clinical Hormone Protocols and Chiropractic Support
A woman is in a consultation with a doctor in a clinic.

Abstract

In this educational post, I present a clear, first-person journey through modern, evidence-based approaches to common hormonal and metabolic challenges I see in practice: iron deficiency and heavy menstrual bleeding, PCOS management, post–gastric bypass considerations, testosterone therapy physiology, contraception risk-benefit decisions in midlife, SHBG-related treatment resistance, and progesterone strategy in premenopause, perimenopause, and menopause. I integrate clinical observations from my work as a chiropractor and advanced practice clinician and show how integrative chiropractic care fits within comprehensive, patient-centered protocols. I highlight practical dosing frameworks, explain underlying physiology—absorption, distribution, and renal excretion—and share how to avoid pitfalls with estrogen modulation, environmental exposures, and breast cancer risk. Throughout, I reference the latest research from leading investigators, link to sources, and offer stepwise algorithms and bullet-pointed checklists you can use in clinical decision-making.

Introduction: Why Multidisciplinary Care Matters in Hormone Health

In my clinical practice, I often begin by assembling the right team around the patient—endocrinology, primary care, women’s health, nutrition, behavioral health, and integrative chiropractic—to ensure we address physiology, biomechanics, lifestyle, and safety. Many of the cases discussed below involve overlapping contributors—iron deficiency, thyroid status, insulin resistance, post-surgical malabsorption, and altered sex-hormone binding globulin (SHBG). Without a comprehensive approach, patients can remain symptomatic despite reasonable therapies.

I use a structured framework:

  • Define the primary symptom drivers: bleeding, fatigue, mood, sleep, weight, libido, and cognition.
  • Screen for common physiological disruptors: iron deficiency, thyroid dysfunction, insulin resistance, chronic inflammation, micronutrient deficiencies, gut dysbiosis.
  • Model hormone kinetics: absorption, distribution, metabolism, and excretion.
  • Map risk-benefit: contraception, vascular risk (DVT), bone health, breast cancer.
  • Layer integrative chiropractic care: neuromusculoskeletal optimization, autonomic regulation, sleep and stress coaching, movement prescriptions, and pain reduction that support endocrine balance.

Iron Deficiency, Heavy Menstrual Bleeding, and Cyclic Progesterone

Many women I see have untreated or under-treated iron deficiency. Heavy menstrual bleeding leads to cumulative iron loss, lowering ferritin and impairing oxygen delivery and mitochondrial function. That drives fatigue, brain fog, exercise intolerance, hair thinning, and altered thermoregulation.

Key physiology:

  • Iron is essential for hemoglobin, myoglobin, mitochondrial electron transport (complexes I–IV), thyroid peroxidase activity, and neurotransmitter synthesis.
  • Low ferritin (<30–50 ng/mL in symptomatic patients) is commonly associated with fatigue, even when hemoglobin remains normal.
  • Copper supports ceruloplasmin and iron mobilization from stores. Low copper can blunt iron’s efficacy.

My evidence-based approach:

  • Assess CBC, ferritin, transferrin saturation, CRP (to interpret ferritin), TSH, free T4, free T3, and B12/folate.
  • Consider cyclic progesterone to stabilize the endometrium and reduce bleeding. In premenopausal heavy bleeding, physiologic micronized progesterone can reduce flow by limiting endometrial proliferation and enhancing orderly shedding.
  • Supplement iron with a well-tolerated chelate (e.g., ferrous bisglycinate) and co-factors:
    • Vitamin C to enhance non-heme iron absorption.
    • Copper (if low), magnesium, and B vitamins to support erythropoiesis.
  • Treat thyroid dysfunction as it contributes to menorrhagia and anemia by altering clotting factors and endometrial function.
  • Use dietary strategies: heme iron sources, polyphenols timed away from iron dosing, and avoiding inhibitors (tea/coffee) around iron intake.

Why cyclic progesterone helps:

  • Progesterone counterbalances estrogen-induced endometrial proliferation.
  • It improves spiral artery stability and reduces prostaglandin-mediated hyperperistalsis and cramping.
  • Cyclic dosing aligns with the luteal phase, supporting more physiologic endometrial responses.

Clinical checklist:

  • Confirm iron deficiency (ferritin and iron studies).
  • Initiate iron plus co-factors; schedule follow-up ferritin/TSAT.
  • Use cyclic micronized progesterone for 2–3 cycles and reassess bleeding.
  • Normalize thyroid function if abnormal.
  • Integrate chiropractic care to address fatigue-related deconditioning and pelvic floor mechanics.

PCOS: Insulin Resistance, Ovulatory Dysfunction, and Progesterone Use

In PCOS, I emphasize insulin-sensitizing strategies, cycle regulation, and endometrial protection.

PCOS physiology:

  • Hyperinsulinemia raises ovarian theca cell androgen production.
  • Altered GnRH pulsatility impairs ovulation; unopposed estrogen exposes the endometrium to proliferative signals, increasing the risk of heavy bleeding.
  • SHBG is often reduced by insulin resistance, increasing free androgens and symptoms (acne, hirsutism).

My protocol:

  • Lifestyle: progressive resistance and aerobic training; sleep optimization; high-fiber, low-glycemic diet; targeted weight reduction.
  • Metabolic supports: inositol (myo- and D-chiro), magnesium, vitamin D, omega-3s; consider metformin or GLP-1 agonists when indicated.
  • Cyclic progesterone can protect the endometrium and regulate bleeding in anovulatory cycles.
  • Monitor lipids, A1c, fasting insulin, LH/FSH ratio, and ultrasound where appropriate.

Why progesterone in PCOS:

  • Provides luteal-phase coverage to reduce endometrial proliferation.
  • May improve sleep and anxiety through GABAergic modulation, supporting adherence to lifestyle changes.

My clinical observation:

  • Adding cyclic progesterone while addressing insulin resistance reduces bleeding within 2–3 cycles and improves energy as ferritin normalizes.

Post–Gastric Bypass and Malabsorption: Gut, Micronutrients, and Hormone Therapy

Post-bariatric patients present unique challenges due to altered anatomy and absorption.

Physiology considerations:

  • Reduced gastric acid and bypassed segments alter the absorption of iron, B12, folate, calcium, vitamin D, and fat-soluble vitamins.
  • Microbiome changes and small intestinal bacterial overgrowth (SIBO) can impair nutrient uptake and mucosal integrity.

My approach:

  • Aggressively test and replace micronutrients: iron, B12, folate, vitamin D, calcium, magnesium, zinc, copper, selenium, vitamins A, E, and K.
  • Use probiotics tailored for upper and lower GI support and consider prebiotics if tolerated.
  • If oral iron is poorly absorbed, consider IV iron repletion.
  • For hormone therapies:
    • Prefer transdermal routes for estrogens/progestins to bypass first-pass metabolism and variable absorption.
    • Use subcutaneous pellet or injectable strategies judiciously, titrating based on symptoms and lab response.
  • Monitor markers of inflammation and renal function since excretion pathways (for testosterone pellets) are renal-dominant.

Integrative chiropractic fit:

  • Address post-surgical biomechanics, core stability, and autonomic balance to reduce pain and improve exercise tolerance, aiding insulin sensitivity and weight maintenance.

Testosterone Therapy Physiology: Absorption, Distribution, and Renal Excretion

When optimizing testosterone, I emphasize three kinetic pillars: absorption, distribution, and excretion.

  • Absorption: For transdermals and pellets, local blood flow and cardiac output matter. Greater capillary perfusion (e.g., regular exercise) increases uptake; patients with sedentary habits may exhibit slower rises.
  • Distribution: Testosterone disperses throughout total body water and adipose compartments. Higher BMI dilutes effective concentration; weight loss reduces distribution volume, potentially increasing exposure at a given dose.
  • Excretion: Testosterone and its metabolites are predominantly renally cleared. Older adults with reduced GFR maintain levels longer; lower doses often suffice with extended duration of effect.

Clinical implications:

  • After significant weight loss (e.g., 250 lb to 190 lb), prior dosing may over-expose; re-calculate based on body composition changes.
  • Elderly males may experience prolonged pellet duration (e.g., 6–9 months) due to slower clearance—dose conservatively and extend intervals.

Managing estrogenic symptoms:

  • Transient breast tenderness in early therapy often reflects a rapid rise in testosterone with aromatization to estradiol. This typically resolves after initial titration.
  • I avoid routine estrogen blockers unless there is clear evidence of persistent symptomatic hyperestrogenism; instead, I optimize dose, timing, and route.
  • If needed, I may use targeted nutraceuticals such as diindolylmethane (DIM) to support balanced estrogen metabolism, but I prefer to correct kinetics first.

Safety and performance myths:

  • Requests for “extra sessions” to get “jacked” rapidly are unsafe and unnecessary; supraphysiologic dosing risks adverse effects and paradoxical sexual dysfunction.
  • I counsel clearly: more is not better; tailored, steady-state physiology produces superior outcomes.

Midlife Contraception, DVT Risk, and Rational Alternatives

Risk-benefit changes with age. In my practice:

  • Young adults on oral contraceptives accept a modestly increased risk of venous thromboembolism (VTE) that often remains acceptable given high contraceptive utility.
  • By ages 40–45+, for women who no longer need contraception (e.g., IUD in place or tubal ligation), continued combined oral contraceptives may present unnecessary VTE and stroke risks.

Practical steps:

  • If the goal is symptom control (PMS, dysmenorrhea, endometriosis), I prefer non-contraceptive hormone strategies: micronized progesterone, low-dose transdermal estradiol balanced with progesterone, or levonorgestrel IUD for local endometrial control.
  • I avoid systemic estrogen-progestin contraceptives in midlife when contraception is not needed.
  • Integrate SHBG dynamics in the decision: high SHBG often blunts the free testosterone response.

SHBG, Free Testosterone, and Clinical Resistance

I frequently see midlife women with high SHBG (e.g., ~115 nmol/L) who report minimal benefit until total testosterone is pushed high—an approach I generally avoid.

Physiology:

  • SHBG binds testosterone and estradiol. Higher SHBG levels reduce free fractions, leading to symptomatic “non-response” despite normal total levels.
  • Estrogen-containing contraceptives elevate SHBG; hyperthyroidism, liver disease, and genetics also contribute.

My strategy:

  • Lower SHBG is influenced by changing the hormonal milieu rather than forcing total testosterone upward.
    • Replace combined oral contraceptives with a levonorgestrel IUD to minimize systemic estrogen contribution to SHBG.
    • Address thyroid status, liver health, and insulin resistance.
  • Aim to optimize free testosterone within physiologic ranges, not inflate total values.

Clinical pearl:

  • Women with high SHBG are often difficult to satisfy symptomatically if contraceptives remain unchanged. Shifting to an IUD and carefully titrating physiological dosing improves mood, energy, libido, and reduces the risk of adverse events.

Progesterone in Premenopause vs Perimenopause and Menopause

I differentiate between contraceptive progestins and physiologic progesterone:

  • In premenopause, progestins in combined oral contraceptives primarily prevent ovulation and pregnancy; they are not designed for symptom modulation alone.
  • In perimenopause and menopause, micronized progesterone is used therapeutically to treat symptoms: sleep disturbance, anxiety, vasomotor instability, and heavy bleeding. It is bioidentical, engages GABA-A receptors, and provides endometrial protection when used with estradiol.

Why use micronized progesterone:

  • Better tolerability and neurosteroid benefits.
  • Lower thrombotic risk compared to some synthetic progestins when paired with transdermal estradiol.
  • Improves sleep architecture and reduces night sweats.

Risk considerations:

  • Certain synthetic progestins combined with oral estrogens may elevate breast cancer risk compared to regimens using transdermal estradiol plus micronized progesterone; I tailor choices based on family history, prior exposures, and current evidence.

Addressing Environmental Exposures and SHBG Modifiers

Patients often ask whether environmental toxins (e.g., lead) significantly alter SHBG or testosterone responses. My stance:

  • While some supplements claim to reduce SHBG by 10–15%, such modest shifts rarely translate to meaningful clinical benefit without changing the hormonal environment.
  • I prioritize root-cause changes: removing exogenous estrogens, stabilizing thyroid and liver function, improving metabolic health, and fine-tuning hormone dosing and route.

Pellet Dosing, Durability, and Renal Considerations

Pellet therapy can be effective when applied thoughtfully:

  • I avoid nightly “stacking” of transdermal testosterone at uniform high doses; chronic overexposure risks dysregulation and breakthrough issues.
  • For heavy bleeding cases, I may cycle a structured progesterone regimen for several months to stabilize the endometrium before introducing or escalating other therapies.
  • In elderly men, reduced renal clearance extends pellet longevity; I plan for longer intervals and lower insertions.

Erectile Dysfunction and Testosterone: Clarifying Misconceptions

I am often asked whether atrial fibrillation or cardioversion interacts adversely with testosterone. Findings suggest:

  • Men with androgen deficiency who normalize testosterone prior to certain cardiac procedures may experience improved outcomes, likely through metabolic and autonomic stabilization.
  • Erectile dysfunction (ED) is multifactorial—vascular, neurologic, and endocrine—and not inherently caused by appropriate testosterone replacement. Careful titration minimizes risks.

I emphasize:

  • Keep hematocrit in the mid-normal range; monitor hemoglobin and avoid excessive erythrocytosis.
  • Target mid-normal total and free testosterone; focus on symptom resolution and safety metrics.

Integrative Chiropractic Care: Biomechanics, Autonomic Balance, and Endocrine Support

Where does integrative chiropractic care fit in?

  • Pain relief and mobility: Reducing nociceptive input lowers the cortisol and catecholamine burden, supporting sex hormone signaling and thyroid function.
  • Autonomic regulation: Cervical and thoracic segmental work may modulate sympathetic-parasympathetic balance, improving sleep, HRV, and stress resilience.
  • Movement prescriptions: Progressive loading enhances insulin sensitivity, bone density, and capillary perfusion—improving hormone absorption and metabolic outcomes.
  • Pelvic alignment and floor function: In heavy bleeding and pelvic pain, optimizing sacral mechanics can reduce cramping and enhance lymphatic drainage, aiding symptom control.
  • Post-bariatric support: Core stabilization and low-impact aerobic plans accommodate altered biomechanics and support long-term weight maintenance.

My clinical observations from ChiroMed:

  • When we combine biomechanical optimization with iron repletion, cyclic progesterone, and metabolic therapy, women report faster improvements in energy and menstrual regularity.
  • In PCOS, structured resistance training guided by chiropractic-informed movement analysis reduces central adiposity and improves ovulatory patterns.
  • In older men on testosterone pellets, a tailored mobility program plus hydration and renal-friendly lifestyle supports steady hormone levels and minimizes adverse effects.

Stepwise Clinical Algorithms and Bullet Points

Heavy bleeding with suspected iron deficiency:

  • Screen: CBC, ferritin, TSAT, CRP, TSH, free T4, free T3.
  • Treat: iron + vitamin C; assess copper and magnesium; cyclic micronized progesterone; address thyroid dysfunction.
  • Follow: ferritin target >50–100 ng/mL depending on symptoms; re-test every 8–12 weeks.
  • Integrate: pelvic biomechanics, stress reduction, sleep support.

PCOS symptom cluster:

  • Labs: fasting insulin, A1c, lipids, LH/FSH, vitamin D; consider ultrasound.
  • Lifestyle: strength + aerobic; high-fiber diet; sleep retraining.
  • Therapy: inositol, magnesium, omega-3; consider metformin/GLP-1; cyclic progesterone for endometrial protection.
  • Chiropractic: movement coaching; pain reduction for adherence.

Post–gastric bypass:

  • Assess: iron, B12, folate, vitamins A/D/E/K, calcium, magnesium, zinc, selenium.
  • Replace: oral vs IV based on tolerance; transdermal hormones favored.
  • GI: targeted probiotics; evaluate SIBO if symptoms persist.
  • Movement: gentle progression to improve perfusion and absorption.

Testosterone optimization:

  • Kinetics: absorption (perfusion), distribution (BMI), excretion (renal).
  • Dosing: titrate after weight change; lower doses in the elderly; avoid supraphysiologic spikes.
  • Monitoring: total/free T, estradiol, hematocrit, PSA (men), symptoms.
  • Avoid routine estrogen blockers; correct underlying kinetics.

Midlife contraception:

  • Reassess need: if no pregnancy risk, minimize systemic estrogen-progestin exposure.
  • Prefer LNG-IUD for bleeding control; use physiologic hormone therapy for symptoms.
  • Consider SHBG effects and tailor accordingly.

SHBG management:

  • Identify contributors: OCPs, thyroid, liver, and insulin resistance.
  • Reduce SHBG influence by changing contraception and optimizing metabolic health.
  • Target free testosterone rather than inflating total levels.

Safety and communication:

  • Educate on risks of overdosing and myths about “extra sessions.”
  • Reinforce adherence and measured titration.
  • Use shared decision-making with transparent lab review.

Conclusion: Precision Protocols with Whole-Person Care

The strongest outcomes arise when we blend precise, physiology-based hormone protocols with integrative chiropractic care and lifestyle medicine. By correcting iron deficiency, stabilizing cycles with progesterone, respecting testosterone kinetics, and rationalizing contraception choices in midlife, we reduce risk and improve quality of life. Each intervention is chosen for a physiologic reason and is tested against symptoms and labs. With careful monitoring and team-based care, patients can achieve durable, meaningful improvements.

References

Personalized Hormone Optimization and Health Support

Personalized Hormone Optimization and Health Support

Personalized Hormone Optimization and Health Support

Abstract

In this educational post, I share my integrative, evidence-based approach to optimizing hormones for women and men—focusing on how declines in testosterone, estradiol, and progesterone can drive anxiety, irritability, sleep fragmentation, low libido, metabolic resistance, and chronic pain. I explain the physiology behind these symptoms, how I layer therapies to honor receptor sensitivity and avoid side effects, and how to select the right route—pellets, injections, patches, creams/gels, or sublingual—based on your goals and biology. I also show how integrative chiropractic care supports autonomic balance, neuromuscular health, and inflammation control, thereby enhancing hormone therapy outcomes. Throughout, I highlight current findings from leading researchers and share clinical observations from my practice to provide you with a clear, practical roadmap you can use with your care team.

Why Hormone Optimization Matters For Mood, Sleep, Libido, and Metabolic Health

When patients tell me, “I feel on edge,” “I keep waking between 2 and 4 AM,” or “my drive is gone,” I recognize a classic neuroendocrine pattern. Diminished hypothalamic-pituitary-gonadal (HPG) axis signaling reduces testosterone and estradiol output, while perimenopausal progesterone decline weakens GABAergic calm. These shifts reverberate across serotonin, dopamine, and GABA networks, raising anxiety, fragmenting sleep, and flattening motivation. Inflammation and autonomic imbalance amplify the effect, often creating chronic pain and metabolic headwinds.

What this means physiologically:

  • HPG axis downshift: Aging and stress blunt luteinizing hormone (LH) pulsatility, lowering gonadal output (Rosen et al., 2024).
  • Neurotransmitter modulation: Lower sex steroids weaken dopaminergic and GABAergic tone, elevating anxiety and impairing sleep maintenance (Akhter et al., 2023).
  • Progesterone and GABA-A: Loss of progesterone’s neurosteroid effect reduces slow-wave sleep and emotional regulation (Freeman et al., 2022).
  • Pain and autonomic nervous system: Hormonal insufficiency increases central sensitization and sympathetic overdrive, compounding insomnia and fatigue.

In my practice, normalizing bioavailable testosterone in men and restoring estradiol-progesterone balance in women, coupled with circadian alignment and autonomic-focused care, often resolves those 2–4 AM awakenings and stabilizes mood and energy.

My Stepwise, First-Person Roadmap: Layering Therapies With Precision

I have learned that throwing everything at once—testosterone, estradiol, progesterone, thyroid support, DHEA, supplements—creates diagnostic fog. Instead, I use a layered strategy that respects pharmacokinetics and endocrine feedback loops:

  • Start with the most likely driver based on symptoms and labs.
  • Add one or two interventions at a time.
  • Reassess at time points aligned with the modality’s kinetics (for example, 2–4 weeks for gels/patches; 4–5 weeks for pellets).
  • Adjust carefully using validated symptom scales (e.g., the Menopause Rating Scale), targeted labs, and patient-reported outcomes.

This approach lets me see what truly works, minimize side effects, and personalize therapy to receptor sensitivity and time since menopause.

References: Menopause Rating Scale (Heinemann et al., 2004)

Testosterone: Why It Matters For Men And Women

Testosterone is not just about muscle; it is a neuro-metabolic hormone:

  • Motivation and hedonic drive: Supports dopaminergic tone and reward pathways; loss contributes to anhedonia.
  • Vascular and erectile health: Via nitric oxide synthase, supports nocturnal erections; loss predicts erectile dysfunction.
  • Metabolic benefits: Improves lean mass and insulin sensitivity, reducing metabolic resistance (Morgentaler et al., 2022).
  • Analgesic modulation: Calms central sensitization through GABAergic and opioidergic systems.

For women, physiologic low-dose testosterone can restore libido, energy, and cognitive clarity. However, women are more sensitive to peaks and cumulative exposure. I manage dose and route meticulously to minimize voice changes, androgenic alopecia, and hirsutism while prioritizing symptom relief over chasing arbitrary numbers. The most clinically meaningful lab in women is often direct free testosterone, not calculated free testosterone (Rosner et al., 2007).

References:

Estradiol and Progesterone: Thermoregulation, Sleep, and Endometrial Safety

Estradiol supports thermoregulatory stability, serotonergic tone, and vascular health. Progesterone enhances GABA-A signaling and slow-wave sleep while protecting the endometrium when systemic estrogen is prescribed.

  • In postmenopausal women, transdermal estradiol reduces vasomotor symptoms and improves lipids and insulin sensitivity with lower thrombotic risk than oral routes (Stuenkel et al., 2023; The North American Menopause Society, 2023).
  • Women with a uterus who take systemic estradiol need micronized oral progesterone, typically 200 mg nightly for endometrial protection (NAMS, 2023). Progesterone creams are not sufficient for this purpose.
  • In perimenopause, estradiol fluctuations are the rule. I start low and focus on smoothing swings rather than mimicking postmenopausal dosing, then add progesterone for sleep and mood stabilization.

References:

Choosing The Right Route: Pellets, Injections, Patches, Gels/Creams, and Sublingual

Pellets: Continuous, Steady-State Delivery

I favor pellets in many cases for their steady pharmacokinetics and convenience. Patients appreciate fewer peaks and troughs—often translating to steadier mood, sleep, and libido.

  • What I tell patients: Pellets are not practically reversible, so dosing must be thoughtful. Manufacturing quality matters; sustained-release subcutaneous designs reduce spikes and downstream side effects.
  • Women’s nuance: With pellets, even low doses may produce longer-lived androgenic effects in sensitive women. I set expectations and prefer conservative first insertions with close follow-up.

Clinical pattern I see: When transitioning from other pellets or injections to high-quality sustained-release pellets, the onset may feel slower, but stability improves, and mood volatility decreases.

Injections: Predictable for Men, Risky Peaks if Undersmoothed

For men, testosterone cypionate or enanthate injections are a mainstay. Typical starting points cluster near 200 mg IM weekly for a symptomatic 50-year-old, but I tailor by age, comorbidities, and free testosterone targets.

  • Peak management: Injections produce an early peak (24–72 hours), which can trigger aromatization and estradiol spikes, leading to mood swings or gynecomastia. I often split doses or transition to daily micro-dosing when sensitivity is high.
  • Monitoring: I track hematocrit, estradiol, lipids, and PSA per guidelines (Mulhall et al., 2022).

References:

Patches and Transdermal Creams/Gels: Absorption and Site Matters

Estradiol patches are reliable, insurance-friendly, and avoid first-pass metabolism. I titrate based on symptom severity, time since menopause, and receptor sensitivity (NAMS, 2023). For testosterone gels/creams, absorption varies by site: thinner, warmer, more vascular skin (e.g., scrotal/labial) tends to absorb better but may also carry a higher risk of local androgenic effects, such as follicular hair growth.

  • Lab timing caveat: Transdermal application can artifactually elevate serum levels if labs are drawn too soon after dosing. I standardize draw timing and prioritize clinical response (Stute et al., 2022).

References:

Sublingual/Rapid-Dissolve Tablets (RDT)

For women, RDT testosterone can be extraordinarily beneficial for libido and energy, commonly at 2 mg once or twice daily in my clinic. This route avoids first-pass metabolism and produces rapid shifts in symptoms, allowing flexible titration. For men, daily RDT requirements are often too high to be practical.

Clomiphene and Fertility-Preserving Strategies in Men

Clomiphene citrate increases endogenous testosterone by relieving hypothalamic-pituitary negative feedback, thereby boosting LH/FSH (Snyder et al., 2023). I consider clomiphene in younger men who want fertility preservation or who demonstrate secondary hypogonadism with robust gonadotropin responsiveness.

  • Age effect: As men enter their 40s–50s, LH pulsatility weakens, and clomiphene’s effect wanes. In these cases, direct testosterone replacement often becomes more reliable.

Reference:

Perimenopause, Menopause, and FSH: Dosing Strategy In Context

A pivotal question I ask every time is: Are cycles still occurring? Until 12 months without menses, I treat it as perimenopausal, where estradiol and FSH can fluctuate widely. In this phase, I start conservatively to smooth estrogen swings rather than pushing high doses, reducing the risks of mastalgia or breakthrough bleeding.

Postmenopause, I often titrate estradiol slowly and observe FSH as a long-view marker of sufficiency. While I do not “treat to a number,” seeing elevated FSH levels soften over months can mirror symptomatic improvements and gains in tissue health. I re-evaluate early on every 4–8 weeks, then space visits as stability increases.

References:

SHBG, Free Hormone, and Why Symptoms Lead

Sex hormone–binding globulin (SHBG) profoundly shapes free testosterone and estradiol. High SHBG can blunt clinical effects; low SHBG can magnify them. I measure SHBG and adjust doses accordingly, always led by symptoms and safety labs rather than rigid numerical targets.

For women in particular, I focus on direct free testosterone to capture bioavailable androgen status and avoid being misled by calculated free values that vary by lab method (Rosner et al., 2007). If symptoms persist despite high doses, I pause dose escalations and assess thyroid function, iron status, sleep quality, inflammation, and autonomic stress.

Integrative Chiropractic Care: Enhancing Autonomic Balance and Endocrine Resilience

Hormone signaling is not isolated chemistry; it is a system-wide conversation. Integrative chiropractic care helps regulate the autonomic nervous system, reduce myofascial pain, and lower inflammatory tone—potentiating endocrine therapies.

What I do in practice:

  • Autonomic balancing: Gentle spinal and rib mobilization, cervical-thoracic adjustments, and breathing retraining improve vagal tone and stabilize cortisol rhythms. Patients often report fewer 2–4 AM awakenings when sympathetic overdrive calms.
  • Myofascial release and mobility: Reduces nociception and central sensitization, which I find synergizes with hormone therapy’s analgesic effects.
  • Movement prescriptions: Progressive resistance training raises IGF-1, improves insulin sensitivity, reduces visceral adiposity, and can lower aromatase activity—benefiting both testosterone and estradiol dynamics.
  • Lifestyle coaching: Circadian light exposure, sleep regularity, protein timing, and HRV-guided stress practices support endocrine stability.

Clinical observations from my practice at ChiroMed:

  • Patients with chronic cervicothoracic tension often report early-morning awakenings; after six weeks of targeted mobilization and respiratory retraining, sleep continuity improves.
  • Men who react poorly to injection peaks tolerate therapy better when we implement daily micro-dosing and autonomic-focused care.
  • Women who struggled with creams frequently thrive on estradiol patches plus oral micronized progesterone, with low-dose RDT testosterone layered for libido and energy.

Supportive references:

Practical Protocols: Matching Route to Patient Needs

For Men

  • Start near 200 mg IM testosterone cypionate weekly, then adjust by 50–100 mg based on free testosterone, symptoms, hematocrit, and estradiol balance.
  • If sensitive to peaks, consider split injections or daily micro-dosing.
  • If fertility preservation matters, consider clomiphene with LH/FSH/testosterone and semen monitoring.
  • Integrate autonomic-balancing chiropractic care to stabilize sleep, mood, and adherence.

For Women

  • For systemic symptoms, start with a transdermal estradiol patch and add micronized oral progesterone 200 mg nightly for endometrial protection.
  • For libido/energy, add low-dose testosterone via RDT (e.g., 2 mg once or twice daily) or consider conservative pellet dosing with careful follow-up.
  • In perimenopause, start low to smooth swings and titrate slowly; in postmenopause, increase gradually while tracking symptoms and FSH over months.

Monitoring framework:

  • Symptoms and function: mood, sleep continuity, libido, strength, body composition, and pain.
  • Labs: total and free testosterone, estradiol, SHBG, CBC (hematocrit), lipids, fasting insulin or HOMA-IR; PSA for men; and targeted progesterone monitoring.
  • Reassess at 6–8 weeks early in therapy, then every 3–6 months.

Side Effects and How I Mitigate Them

  • Hirsutism (women): Lower dose, change route (e.g., RDT instead of pellets), or split dosing to avoid peaks.
  • Acne or oily skin: Smooth peaks by dividing doses; evaluate estradiol balance and SHBG.
  • Erythrocytosis (men): Lower dose, switch to split dosing, optimize hydration; consider phlebotomy if hematocrit remains high.
  • Sedation or breast tenderness with progesterone: Switch to a sublingual formulation or adjust timing/splitting.
  • Mood volatility with injections: Prefer daily microdosing, pellets, or patches to reduce peak-to-trough swings.

Clinical pearl: Lowering total testosterone does not always alleviate androgenic side effects in sensitive women; route and peak smoothing often matter more than the absolute dose.

Special Topics: Menstrual Migraine, SSRIs, and Lab Timing

  • Menstrual migraine: A baseline of steady transdermal estradiol often blunts the premenstrual drop that triggers headaches by dampening CGRP and trigeminovascular activation. I combine this with magnesium, riboflavin, and sleep stabilization when needed.
  • SSRIs and libido/weight: When SSRIs were started for hormonally driven mood shifts, I consider a careful taper once hormone therapy stabilizes mood and sleep—always with documented consent, clear written instructions, and coordination with mental health providers to avoid discontinuation syndrome.
  • Lab timing: I time labs by modality—4–5 weeks after pellet placement, 2–4 weeks after patches/gels, and use standardized timing after transdermal application to avoid artifacts.

References:

Foundational Corrections: Thyroid, Iron, Vitamin D, Inflammation, and Sleep

Hormone therapy works best on a solid physiologic foundation. I routinely evaluate and correct:

  • Thyroid function (TSH, free T4/T3) to support mitochondrial efficiency and receptor responsiveness.
  • Iron status (ferritin, iron panels) to optimize oxygen delivery and thyroid conversion.
  • Vitamin D for immune and endocrine modulation.
  • Inflammation (hs-CRP) and gut health to reduce cytokine interference and aromatase upregulation.
  • Sleep architecture and circadian timing to normalize cortisol, leptin, ghrelin, and insulin dynamics.

Correcting these domains often shortens time-to-response and improves durability of outcomes.

Clinical Vignettes From My Practice

  • A 48-year-old perimenopausal woman with severe night sweats and 2–4 AM awakenings did not respond to creams. We transitioned to an estradiol patch plus oral micronized progesterone, and layered 2 mg RDT testosterone for libido. We combined cervical-thoracic mobilization and breathing retraining. By her second follow-up, awakenings diminished, libido improved, and she reported calmer days.
  • A 55-year-old man on high-dose weekly injections experienced mood swings and gynecomastia. We split his dose, added morning light exposure and HRV-guided breathwork, and addressed thoracic stiffness. Symptoms eased, energy stabilized, and labs normalized.
  • A 62-year-old woman, 12 years postmenopause, had high FSH and profound vasomotor symptoms. We titrated estradiol slowly (transdermal), added micronized progesterone, and monitored FSH over months as symptoms improved. Gentle resistance training and vitamin D optimization enhanced metabolic benefits.

Safety, Shared Decision-Making, and Documentation

  • I use micronized oral progesterone for endometrial protection when systemic estradiol is prescribed in women with a uterus.
  • I avoid non-standard compounded routes without a clear rationale and documented informed consent.
  • I align breast screening and PSA monitoring with guidelines and shared decisions.
  • I standardize follow-up intervals, written instructions (e.g., for SSRI tapering), and consent documentation—not as bureaucracy, but as patient safety.

Putting It All Together: A Modern, Integrative Pathway

  • Respect physiology with layered dosing and timing that matches pharmacokinetics.
  • Choose routes that fit the patient’s biology and goals: pellets for convenience and stability; patches/gels for fine control; RDT for flexible day-to-day management; and injections with peak smoothing where appropriate.
  • Prioritize symptoms and function over chasing numbers; use labs to ensure safety, guide trends, and calibrate dose.
  • Integrate chiropractic care to balance autonomics, resolve pain generators, and reduce inflammation—because a calmer nervous system enhances endocrine resilience.
  • Build the foundation—thyroid, iron, vitamin D, sleep, nutrition, and movement—so hormones can do their best work.

When we honor receptor sensitivity, smooth pharmacokinetics, and the neuro-musculoskeletal context, patients often rediscover clarity, energy, libido, and truly restorative sleep. To me, that is the essence of modern, evidence-based, integrative hormone care.

References

Hormone Health, Metabolism, and Prostate Wellness

Hormone Health, Metabolism, and Prostate Wellness

Hormone Health, Metabolism, and Prostate Wellness

Abstract

In this educational post, I take you through a practical, clinician-tested roadmap to understanding and treating hormone-related metabolic dysfunctions across the lifespan—particularly the interplay among sex hormone–binding globulin (SHBG), insulin resistance, polycystic ovary syndrome (PCOS), DHEA dynamics, and prostate-specific antigen (PSA) decision-making for men’s health. Drawing on current research and my clinical observations at Chiromed and in integrative practice, I explain why SHBG is not your enemy, how gut-driven insulin resistance amplifies androgen effects, how to identify PCOS phenotypes that do not look “typical,” and how to merge modern therapeutics (GLP-1s, metformin, spironolactone) with lifestyle, nutrition, and integrative chiropractic care to restore function. I also walk through PSA interpretation using percent free PSA and velocity, and when to order a 3T multiparametric prostate MRI. You will find physiologic context, step-by-step reasoning, and practical protocols you can apply immediately.

Key topics that follow

  • SHBG physiology, clinical meaning, and why chasing a lower SHBG is usually counterproductive
  • Insulin resistance, the gut–ovary axis, and PCOS phenotypes and treatment logic
  • Practical dosing pearls for metformin, GLP-1 receptor agonists, and spironolactone
  • DHEA physiology, neurological roles, and targeted use in men and women
  • PSA, percent free PSA, velocity, and the role of 3T multiparametric MRI
  • Where integrative chiropractic, movement therapy, and neuromusculoskeletal care fit into endocrine-metabolic care plans

Understanding SHBG, Free Testosterone, and Metabolic Health

I often meet patients who are symptomatic for low testosterone despite “normal” total testosterone. The missing piece is frequently sex hormone–binding globulin (SHBG)—a carrier protein synthesized in the liver that binds androgens (with a higher affinity for testosterone than for estradiol) and regulates the amount of hormone that is free and bioavailable to occupy intracellular receptors.

Core physiology, clearly explained

  • SHBG binds circulating androgens. Bound hormone is transport-ready but not freely available to cross the cell membrane and activate intracellular androgen receptors.
  • The fraction that remains free (or loosely albumin-bound) is bioavailable and exerts physiologic effects in target tissues (muscle, brain, bone, skin, reproductive organs).
  • Hepatic SHBG synthesis is modulated by insulin, estrogen, and thyroid status. Hyperinsulinemia suppresses SHBG; estrogen and thyroid hormone tend to raise it.
  • Clinically, a low SHBG often signals insulin resistance, while a higher SHBG is frequently associated with favorable metabolic profiles.

Why this matters clinically

  • Patients with low SHBG often present with features of metabolic syndrome—even when A1c still looks “fine.” Multiple cohorts show that low SHBG is a predictive marker for insulin resistance, dysglycemia, and cardiometabolic risk in both women and men (Ding et al., 2009; Selva et al., 2007).
  • Chasing a lower SHBG to “free up” testosterone usually misses the root cause and may worsen risk. Raising insulin (e.g., by overeating refined carbohydrates) can drop SHBG, but at a clear metabolic cost.

Evidence snapshot

  • Prospective data indicate that low SHBG predicts incident type 2 diabetes in women and men independent of BMI and baseline glucose (Ding et al., 2009).
  • Mechanistically, hepatic insulin signaling downregulates SHBG gene expression (Selva et al., 2007), providing a direct pathway from insulin resistance to low SHBG.

Treatment logic you can trust

  • Goal: Improve insulin sensitivity and the liver’s metabolic set point rather than artificially forcing SHBG down.
  • When symptomatic hypogonadism coexists with low SHBG, you may need to “saturate” androgen receptors by optimizing total testosterone so that the available free fraction reaches clinical effectiveness. The parallel, long-term fix is to address metabolic drivers that normalize SHBG.

Integrative chiropractic fit

  • In our practice, optimized movement patterns, resistance training, and autonomic balance through chiropractic care and neuromusculoskeletal rehabilitation improve insulin sensitivity, lower systemic inflammation, and support hepatic health—mechanisms that indirectly help normalize SHBG. I find that restoring spinal mechanics and reducing pain enables patients to engage in consistent physical activity, a cornerstone for improving insulin signaling (see my practice observations at Chiromed).

PCOS, Insulin Resistance, and the Gut–Ovary Axis

PCOS is one of the most common endocrine disorders in women of reproductive age. Yet, it is easy to miss because many patients lack the classic triad of obesity, acne, and hirsutism. I routinely see athletic women with irregular cycles, dysmenorrhea, or infertility—sometimes the only obvious clue—who nonetheless have the hormonal signature of PCOS.

Current diagnostic framework

  • Rotterdam criteria: Diagnose PCOS when at least 2 of 3 are present:
    • Oligo- or anovulation (e.g., irregular or skipped cycles)
    • Clinical/biochemical hyperandrogenism (e.g., hirsutism, acne, elevated free testosterone)
    • Polycystic ovarian morphology (PCOM) on ultrasound
  • Note: Not all patients have ovarian cysts, and total testosterone may be normal while free testosterone is elevated due to low SHBG.

Useful lab patterns

  • Elevated LH: FSH ratio (often >2:1) in some premenopausal patients.
  • Low or low-normal SHBG, elevated free testosterone; often high DHEA-S in adrenal-dominant phenotypes.
  • Early insulin abnormalities and low SHBG can precede changes in A1c.

Why insulin resistance drives PCOS

  • Hyperinsulinemia stimulates theca cells in the ovary to increase androgen production while simultaneously suppressing hepatic SHBG synthesis, thereby increasing free androgens (Escobar-Morreale, 2018).
  • Gut dysbiosis and endotoxemia (LPS exposure) promote low-grade inflammation and worsen insulin signaling, propagating ovarian dysfunction (Zhang et al., 2019).

Atypical PCOS phenotypes I see

  • Lean, athletic women with:
    • Severe dysmenorrhea or irregular cycles
    • Elevated LH: FSH
    • High free T with normal total T
    • High DHEA-S
    • Minimal or no hirsutism/acne

This pattern demands a gut–metabolic workup even when body composition appears healthy. I frequently include stool microbiome testing when symptoms suggest dysbiosis.

Evidence-Based Treatment Algorithms for PCOS

My approach integrates metabolic therapy, targeted pharmacology, nutrition, and neuromusculoskeletal care.

  1. Normalize insulin signaling
  • Metformin: Start low (e.g., 500 mg nightly) and titrate slowly to 1,500–2,000+ mg/day as tolerated to reduce hepatic gluconeogenesis and improve insulin sensitivity. GI side effects often attenuate with gradual titration and extended-release forms (Rena et al., 2017).
  • GLP-1 receptor agonists (e.g., semaglutide, exenatide): Improve glucose-dependent insulin secretion, delay gastric emptying, reduce appetite, and facilitate weight loss; randomized trials show improved metabolic and reproductive outcomes in PCOS (Kahal et al., 2021; Elkind-Hirsch et al., 2008).
  • Mechanistic payoff: Lower insulin raises SHBG and reduces androgenic “noise,” restoring ovulatory signaling.
  1. Manage androgenic symptoms while root-cause care takes hold
  • Spironolactone: An aldosterone antagonist with androgen receptor–blocking activity; effective for hirsutism, acne. Typical doses 50–100 mg/day; allow 6–12 months for maximal effect (Brown et al., 2009).
  • Combined oral contraceptives (COCs) with antiandrogenic progestins (e.g., drospirenone-containing formulations) can raise SHBG and reduce free T; useful for cycle control and symptom relief when pregnancy is not desired (Teede et al., 2018).
  • Caution: Symptom control does not correct the insulin–ovary axis; keep metabolic therapy central.
  1. Nutrition, gut health, and inflammation
  • Anti-inflammatory, Mediterranean-style diet with adequate protein, fiber, and omega-3 fatty acids improves insulin sensitivity and reduces ovarian androgen production (Barrea et al., 2019).
  • Intermittent fasting (time-restricted eating) may improve insulin sensitivity and weight in appropriately selected patients; ensure adequate caloric intake and avoid in those with disordered eating tendencies (Patterson & Sears, 2017).
  • Microbiome support: Address dysbiosis, SIBO, and intestinal permeability where indicated; diet, prebiotic fiber, and evidence-based probiotics can improve metabolic parameters.
  1. Movement and integrative chiropractic
  • Consistent resistance training and aerobic exercise improve GLUT4 translocation, mitochondrial function, and insulin sensitivity. In my clinic, we pair individualized spinal and joint care with corrective exercise to reduce pain-related movement avoidance and enhance adherence.
  • Autonomic balance matters: Many PCOS patients show sympathetic dominance; hands-on care and breathing-based neuromuscular retraining can reduce allostatic load and support ovulatory recovery.
  1. Fertility trajectory
  • Expect cycles and ovulation to normalize over months to years as insulin sensitivity improves. I have seen patients regain regular ovulation and conceive after systematic, sustained metabolic and gut care—even in those previously considered “lean and healthy.”

Clinical pearls and cautions

  • Start androgen therapy cautiously in PCOS or insulin-resistant women with low SHBG. Given the higher free fraction, standard doses can overshoot, increasing the risk of side effects. Start low and titrate slowly if testosterone therapy is clinically indicated for other reasons.
  • Obtain LH and androgen panels in premenopausal patients with menstrual complaints or infertility—even if phenotype is nonclassic.
  • Consider GI testing (e.g., stool analysis) when symptoms or history suggest dysbiosis, IBS, or food-triggered inflammation.

SHBG: What to Avoid and What to Embrace

Common misconception

  • “Lower SHBG to increase free T.” This treats the lab number, not the disease process.

What to avoid

  • Strategies that raise insulin (e.g., high refined carbohydrate load) just to lower SHBG.
  • Unnecessary suppression of SHBG may worsen cardiometabolic risk.

What to embrace

  • Improve insulin sensitivity through nutrition, exercise, sleep optimization, stress modulation, and gut care.
  • Use medications like metformin and GLP-1 receptor agonists to shift the metabolic field when lifestyle alone is insufficient.

In my practice, when we prioritize insulin sensitivity and inflammation control, SHBG trends upward into healthier ranges, free testosterone normalizes relative to total testosterone, and symptoms improve without chasing lab artifacts.

PSA, Percent Free PSA, and Prostate MRI: Smarter Men’s Health

PSA screening has evolved. A single total PSA value is an imperfect signal. Two tools improve decision-making:

  • Percent free PSA (%fPSA): The fraction of PSA not bound to serum proteins. Lower %fPSA indicates a higher likelihood of malignancy at a given total PSA.
  • PSA velocity: The year-over-year change in PSA. Faster rises suggest higher risk.

How I interpret PSA in practice

  • If total PSA is elevated (e.g., >4.0 ng/mL), I obtain percent free PSA. General rules supported by meta-analyses:
    • %fPSA <10% = higher probability of prostate cancer
    • %fPSA 10–20% = intermediate zone; consider prostatitis treatment if symptomatic and retest in ~3 months
    • %fPSA >20% = lower probability; continue surveillance
  • Consider PSA velocity: An increase >0.35–2.0 ng/mL/year—context-dependent—merits further evaluation even if the absolute PSA is “within range” (Vickers et al., 2011).
  • Many benign factors elevate total PSA—intercourse, cycling, digital stimulation, BPH, prostatitis—but they do not significantly affect %fPSA, which is why I lean on percent free PSA for triage.

Imaging that changes outcomes

  • If risk remains concerning (low %fPSA, rapid velocity, suspicious DRE, or persistent PSA elevation), I order a 3 Tesla multiparametric prostate MRI (mpMRI). This modality improves lesion detection and helps target biopsies, reducing unnecessary procedures (Ahmed et al., 2017).
  • Most patients prefer an MRI over immediate biopsy, and mpMRI adds diagnostic clarity, including detection of chronic or acute prostatitis—a common cause of PSA bumps that I diagnose frequently.

Practical pearls

  • Finasteride lowers total PSA by roughly ~50% but does not meaningfully change %fPSA—interpretation should be adjusted accordingly.
  • Counsel patients to avoid prostate stimulation (e.g., ejaculation, vigorous cycling) for 48–72 hours before PSA sampling to reduce noise in total PSA.
  • If PSA and %fPSA suggest low risk, recheck in 3 months rather than rushing to biopsy.

Testosterone therapy timing

  • When PSA and urologic evaluation are reassuring, testosterone therapy can proceed with routine monitoring. I coordinate closely with urology, recognizing that practice styles vary.

DHEA Physiology, Brain Receptors, and When to Treat

Dehydroepiandrosterone (DHEA) and its sulfated form, DHEA-S, are produced primarily by the adrenal cortex and function as both endocrine prohormones and neurosteroids, with receptors and actions in the brain. Levels peak in the 20s and decline steadily with age. In both sexes, suboptimal DHEA can present as low vitality, depressed mood, impaired stress tolerance, and reduced sexual function—even when testosterone looks “good.”

Why DHEA matters

  • Neurosteroid action: DHEA modulates GABAergic and glutamatergic tone, supporting mood, cognition, and arousal (Maninger et al., 2009).
  • Peripheral conversion: DHEA can be converted to androgens and estrogens via tissue-specific enzymes; in women, a portion is converted to DHT in peripheral tissues, contributing to libido and sexual response.
  • Immunometabolic effects: DHEA has anti-inflammatory properties and may influence endothelial function and bone metabolism.

Clinical patterns I see

  • Women with adequate total and free testosterone who remain symptomatic for low libido or anorgasmia sometimes have low DHEA-S in the double digits. Carefully titrated DHEA supplementation often improves sexual function and overall well-being.
  • In men and women with persistent fatigue and low mood despite thyroid/hormone optimization, DHEA can be the missing link.

Dosing logic

  • I typically optimize thyroid and sex hormones first; DHEA often rises when metabolic stress decreases.
  • If DHEA-S remains suboptimal:
    • Women: 5–10 mg/day compounded DHEA; reassess at ~6 weeks
    • Men: 20 mg/day compounded DHEA; reassess at ~6 weeks
    • Over-the-counter options vary in potency; when used, I start around 25 mg/day with close follow-up.
  • Monitor for androgenic side effects, especially in PCOS (who often already have high DHEA-S); avoid in hyperandrogenic phenotypes.

Evidence notes

  • Studies link low DHEA-S to reduced well-being, depression, and sexual dysfunction, with improvements seen in targeted supplementation cohorts (Arlt et al., 1999; Wierman et al., 2014). Age-associated decline is robust and correlates with multiple health outcomes.

Why Integrative Chiropractic Care Belongs in Endocrine-Metabolic Programs

The neuromusculoskeletal system interfaces with the endocrine and immune systems through shared inflammatory and autonomic pathways. Here is how integrative chiropractic care fits, based on observations from my clinic and the scientific literature:

Mechanistic bridges

  • Inflammation: Chronic pain amplifies IL-6 and TNF-α signaling, worsening insulin resistance. By reducing nociceptive drive and improving joint mechanics, manual therapies can lower inflammatory load and facilitate activity.
  • Autonomic balance: Spinal and rib mechanics influence sympathetic/parasympathetic tone. Improved thoracic mobility and diaphragmatic function promote vagal activity, which supports glycemic control and gut motility—both key to the gut–ovary axis.
  • Movement competency: Targeted strength and mobility programs enhance GLUT4 activity in skeletal muscle, thereby improving insulin sensitivity and supporting healthy SHBG levels.

In practice at Chiromed

  • We build individualized plans that synchronize:
    • Spinal and extremity joint care to enable pain-free training
    • Progressive resistance training emphasizing posterior chain and hip mechanics
    • Aerobic conditioning at sustainable intensities
    • Breathing retraining and sleep hygiene to normalize cortisol rhythms
  • This approach improves adherence to metabolic prescriptions, enabling the nutrition and pharmacology to “land” in real life.

Search-optimized section title Practical Protocols and Case-Style Reasoning

Putting it all together, here is how I apply the logic in daily care.

When SHBG is low, and symptoms suggest androgen deficiency

  • Evaluate metabolic health: fasting insulin, lipids, liver enzymes, hs-CRP, A1c.
  • Address insulin resistance first-line with nutrition, exercise, sleep, and stress management; consider metformin and/or GLP-1 RAs.
  • If symptoms persist, carefully optimize testosterone with awareness that low SHBG increases free fraction—start low, titrate to symptom relief and physiologic targets.

When PCOS is likely, but the phenotype is atypical

  • Order LH, FSH, total and free T, SHBG, DHEA-S, fasting insulin/glucose, and consider stool testing.
  • Begin metabolic therapy plus symptom-directed therapy (spironolactone or COCs if appropriate and pregnancy not desired).
  • Integrate resistance training and chiropractic-guided movement plans to accelerate insulin sensitivity and ovulatory recovery.

When initiating or adjusting DHEA

  • Confirm suboptimal DHEA-S and symptom alignment (low mood, libido, vitality).
  • Start low, reassess in 6–8 weeks, and monitor for androgenic side effects.
  • Avoid in hyperandrogenic PCOS unless clearly indicated and monitored.

When PSA is elevated or changing fast

  • Obtain percent free PSA and calculate velocity.
  • If %fPSA <10% or velocity is concerning, proceed to 3T mpMRI; if prostatitis is suspected, treat and retest.
  • Collaborate with urology based on mpMRI and clinical findings; delay testosterone changes until evaluation clarifies risk.

Why We Use Each Technique: The Physiology Behind the Protocols

  • Metformin: Reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity via AMPK activation; lowers insulin, allowing SHBG to normalize and free T to calm down.
  • GLP-1 receptor agonists: Enhance glucose-dependent insulin secretion, reduce appetite, and reduce systemic inflammation; improved ovulatory function reported in PCOS.
  • Spironolactone: Direct androgen receptor blockade plus inhibition of 5α-reductase at higher doses; symptom relief while metabolic causes are corrected.
  • DHEA: Restores neurosteroid tone and supports sexual function with selective peripheral conversion; used when clinically and biochemically indicated.
  • Integrative chiropractic and movement: Improves neuromechanics and reduces pain, enabling training volume and intensity that improve insulin sensitivity; enhances autonomic balance affecting gut and endocrine axes.

Final Takeaways for Patients and Providers

  • Think metabolically first: Low SHBG is often a metabolic distress signal, not a target to suppress.
  • PCOS can be lean and subtle: Free T, LH: FSH, and DHEA-S mapping, plus gut assessment, can catch atypical cases.
  • Combine symptom control and root-cause therapy: Use spironolactone or COCs for hirsutism/acne while you restore insulin sensitivity and gut health.
  • Use smarter PSA strategies: Percent free PSA and PSA velocity reduce unnecessary biopsies and guide timely imaging with 3T mpMRI.
  • Integrate care: When manual therapy, structured exercise, and metabolic medicine are aligned, recovery timelines shorten and outcomes improve.

References

Ahmed, H. U., El-Shater Bosaily, A., Brown, L. C., Gabe, R., Kaplan, R., Parmar, M. K., … Emberton, M. (2017). Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet, 389(10071), 815–822.

Arlt, W., Callies, F., van Vlijmen, J. C. M., Koehler, I., Reincke, M., Bidlingmaier, M., … Allolio, B. (1999). Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine, 341(14), 1013–1020.

Barrea, L., Marzullo, P., Muscogiuri, G., Di Somma, C., De Alteriis, G., Colao, A., & Savastano, S. (2019). Nutritional aspects of PCOS: an update. Advances in Nutrition, 10(2), 270–292.

Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. (2009). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, (2), CD000194.

Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C.-C., Rifai, N., … Liu, S. (2009). Sex hormone–binding globulin and risk of type 2 diabetes in women and men. JAMA, 301(17), 1777–1786.

Elkind-Hirsch, K., Marrioneaux, O., Bhushan, M., Vernor, D., & Bhushan, R. (2008). Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in obese polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 93(7), 2670–2678.

Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Human Reproduction Update, 24(6), 671–698.

Kahal, H., Aburima, A., Ungvari, T., Rigby, A. S., Coady, A. M., Vince, R. V., & Kilpatrick, E. S. (2021). The effect of GLP-1 receptor agonists on cardiovascular risk factors in women with PCOS. Endocrine, 71, 199–206.

Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of DHEA and DHEA-S. Psychoneuroendocrinology, 34(3), 273–286.

Patterson, R. E., & Sears, D. D. (2017). Metabolic effects of intermittent fasting. Annual Review of Nutrition, 37, 371–393.

Rena, G., Hardie, D. G., & Pearson, E. R. (2017). The mechanisms of action of metformin. Nature Reviews Molecular Cell Biology, 19(1), 31–44.

Selva, D. M., Hogeveen, K. N., Innis, S. M., & Hammond, G. L. (2007). Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone–binding globulin gene. Journal of Clinical Investigation, 117(12), 3979–3987.

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., … International PCOS Network. (2018). Recommendations from the international evidence-based guideline for the assessment and management of PCOS. Human Reproduction, 33(9), 1602–1618.

Vickers, A. J., Savage, C., O’Brien, M. F., Lilja, H. (2011). Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. Journal of Clinical Oncology, 29(33), 447–453.